UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_________________________________________________________________

FORM 10-Q

_________________________________________________________________

(Mark One)


x			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~August~~November 2423, 2025


o			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 1-37830

_________________________________________________________________

LAMB WESTON HOLDINGS, INC.

(Exact name of registrant as specified in its charter)


Delaware						61-1797411
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

599 S. Rivershore Lane Eagle, Idaho						83616
(Address of principal executive offices)						(Zip Code)

(208) 938-1047

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $1.00 par value

New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of ~~September~~December 2312, 2025, the Registrant had ~~139~~138,~~352~~879,~~480~~884 shares of common stock, par value $1.00 per share, outstanding.

Table of Contents

Part I. FINANCIAL INFORMATION
	Item 1	Financial Statements (Unaudited)
		Consolidated Statements of Earnings	3
		Consolidated Statements of Comprehensive Income	4
		Consolidated Balance Sheets	5
		Consolidated Statements of Stockholders’ Equity	6
		Consolidated Statements of Cash Flows	7
		Condensed Notes to Consolidated Financial Statements (Unaudited)	8
	Item 2	Management'’s Discussion and Analysis of Financial Condition and Results of Operations	1819
	Item 3	Quantitative and Qualitative Disclosures About Market Risk	2528
	Item 4	Controls and Procedures	2629
Part II. OTHER INFORMATION			2729
	Item 1	Legal Proceedings	2729
	Item 1A	Risk Factors	2729
	Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	2730
	Item 3	Defaults Upon Senior Securities	2730
	Item 4	Mine Safety Disclosures	2730
	Item 5	Other Information	2730
	Item 6	Exhibits	2831
Signature			2932

Table of Contents

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (Unaudited)

Lamb Weston Holdings, Inc.

Consolidated Statements of Earnings

(unaudited, in millions, except per share amounts)

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	August 24,2025		August 25,2024
	November 23,2025		November 24,2024		November 23,2025		November 24,2024
Net sales	$	1,~~659~~618.31	$	1,~~654~~600.19	$	3,277.3	$	3,255.0
Cost of sales	1,~~316~~293.98		1,~~298~~323.1		2,610.6		2,621.2
Gross profit	~~342~~324.43		~~356~~277.08		666.7		633.8
Selling, general and administrative expenses	~~153~~171.60		~~143~~184.97		324.6		328.6
Restructuring expense	3214.31		—74.6		46.4		74.6
Income from operations	~~156~~139.52		~~212~~18.15		295.7		230.6
Interest expense, net	4344.73		4543.23		88.0		88.5
Income before income taxes and equity method earnings	112.8		166.9
Income (loss) before income taxes and equity method earnings	94.9		(24.8)		207.7		142.1
Income tax expense	4736.90		5013.84		83.9		64.2
Equity method investment earnings (loss)	(0.6)		11.3
Equity method investment earnings	3.2		2.1		2.6		13.4
Net income	$	64.3	$	127.4
Net income (loss)	$	62.1	$	(36.1)	$	126.4	$	91.3
Earnings per share:
Basic	$	0.4645	$	(0.8925)	$	0.91	$	0.64
Diluted	$	0.4644	$	(0.8825)	$	0.90	$	0.64
Weighted average common shares outstanding:
Basic	139.54		~~143~~142.68		139.4		143.2
Diluted	139.86		~~144~~143.2		139.7		143.7

See Condensed Notes to Consolidated Financial Statements.

Table of Contents

Lamb Weston Holdings, Inc.

Consolidated Statements of Comprehensive Income

(unaudited, dollars in millions)

	Thirteen weeks ended August 24, 2025						Thirteen weeks ended August 25, 2024
	Thirteen weeks ended November 23, 2025						Thirteen weeks ended November 24, 2024
	Pre-TaxAmount		Tax(Expense)Benefit		After-TaxAmount		Pre-Tax Amount		Tax (Expense) Benefit		After-Tax Amount
Net income	$	112.2	$	(47.9)	$	64.3	$	178.2	$	(50.8)	$	127.4
Net income (loss)	$	98.1	$	(36.0)	$	62.1	$	(22.7)	$	(13.4)	$	(36.1)
Other comprehensive income (loss):
Unrealized pension and post-retirement benefit obligations gain (loss)	6.3		(1.0)		5.3		(0.2)		—		(0.2)
Unrealized pension and post-retirement benefit obligations loss	(0.1)		—		(0.1)		—		—		—
Unrealized currency translation gains	41.3		—		41.3		56.6		(0.6)		56.0
Unrealized currency translation losses	(19.4)		—		(19.4)		(117.8)		1.1		(116.7)
Other	—		—		—		(0.21)		~~0.1~~—		(0.1)
Comprehensive income	$	159.8	$	(48.9)	$	110.9	$	234.4	$	(51.3)	$	183.1
Comprehensive income (loss)	$	78.6	$	(36.0)	$	42.6	$	(140.6)	$	(12.3)	$	(152.9)


	Twenty-Six Weeks Ended November 23, 2025						Twenty-Six Weeks Ended November 24, 2024
	Pre-Tax Amount		Tax (Expense) Benefit		After-Tax Amount		Pre-Tax Amount		Tax (Expense) Benefit		After-Tax Amount
Net income	$	210.3	$	(83.9)	$	126.4	$	155.5	$	(64.2)	$	91.3
Other comprehensive income (loss):
Unrealized pension and post-retirement benefit obligations gain (loss)	6.2		(1.0)		5.2		(0.2)		—		(0.2)
Unrealized currency translation gains (losses)	21.9		—		21.9		(61.2)		0.5		(60.7)
Other	—		—		—		(0.3)		0.1		(0.2)
Comprehensive income	$	238.4	$	(84.9)	$	153.5	$	93.8	$	(63.6)	$	30.2

See Condensed Notes to Consolidated Financial Statements.

Table of Contents

Lamb Weston Holdings, Inc.

Consolidated Balance Sheets

(unaudited, dollars in millions, except share data)

	August 24, 2025		May 25, 2025
	November 23, 2025		May 25, 2025
ASSETS
Current assets:
Cash and cash equivalents	$	9882.67	$	70.7
Receivables, net of allowances of $0.9 and $0.9	772.7		781.6
Receivables, net of allowances of $1.0 and $0.9	742.2		781.6
Inventories	~~906~~1,117.8		1,035.4
Prepaid expenses and other current assets	9568.23		145.0
Total current assets	12,~~873~~011.30		2,032.7
Property, plant and equipment, net	3,~~686~~652.79		3,687.9
Operating lease assets	~~117~~118.72		113.2
Goodwill	1,~~113~~099.75		1,090.2
Intangible assets, net	~~114~~110.59		114.0
Other assets	~~330~~338.85		354.6
Total assets	$	7,~~236~~331.70	$	7,392.6
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings	$	~~215~~187.40	$	370.8
Current portion of long-term debt and financing obligations	8182.87		77.8
Accounts payable	~~544~~709.92		616.4
Accrued liabilities	~~415~~424.92		411.0
Total current liabilities	1,~~258~~403.01		1,476.0
Long-term liabilities:
Long-term debt and financing obligations, excluding current portion	3,~~670~~648.9		3,682.8
Deferred income taxes	~~264~~273.03		253.5
Other noncurrent liabilities	~~254~~251.03		242.6
Total long-term liabilities	4,~~188~~173.95		4,178.9
Commitments and contingencies
Stockholders’ equity:
Common stock of $1.00 par value, 600,000,000 shares authorized; 151,832,842 and 151,390,267 shares issued	151.8		151.4
Common stock of $1.00 par value, 600,000,000 shares authorized; 152,006,164 and 151,390,267 shares issued	152.0		151.4
Treasury stock, at cost, 12,497,431 and 12,152,507 common shares	(856.7)		(838.0)
Treasury stock, at cost, 13,126,699 and 12,152,507 common shares	(897.4)		(838.0)
Additional distributed capital	(~~468~~453.27)		(479.1)
Retained earnings	2,~~861~~871.89		2,848.9
Accumulated other comprehensive income	~~101~~81.16		54.5
Total stockholders’ equity	1,~~789~~754.84		1,737.7
Total liabilities and stockholders’ equity	$	7,~~236~~331.70	$	7,392.6

See Condensed Notes to Consolidated Financial Statements.

Table of Contents

Lamb Weston Holdings, Inc.

Consolidated Statements of Stockholders’ Equity

(unaudited, dollars in millions, except share and per share data)

	Thirteen Weeks Ended August 24, 2025 and August 25, 2024
	Thirteen Weeks Ended November 23, 2025 and November 24, 2024
	Common Stock,net of TreasuryShares	CommonStockAmount		TreasuryStockAmount		Additional Paid-in(Distributed)Capital		RetainedEarnings		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity
Balance at May 25, 2025	139,237,760	$	151.4	$	(838.0)	$	(479.1)	$	2,848.9	$	54.5	$	1,737.7
Dividends declared, $0.37 per share	—	—		—		—		(51.6)		—		(51.6)
Common stock issued	442,575	0.4		—		(0.4)		—		—		—
Stock-settled, stock-based compensation expense	—	—		—		10.6		—		—		10.6
Repurchase of common stock and common stock withheld to cover taxes	(344,924)	—		(18.7)		—		—		—		(18.7)
Other	—	—		—		0.7		0.2		—		0.9
Comprehensive income	—	—		—		—		64.3		46.6		110.9
Balance at August 24, 2025	139,335,411	$	151.8	$	(856.7)	$	(468.2)	$	2,861.8	$	101.1	$	1,789.8
Balance at May 26, 2024	143,666,656	$	150.7	$	(540.9)	$	(508.9)	$	2,699.8	$	(12.9)	$	1,787.8
Dividends declared, $0.37 per share	—	—		—		—		(51.4)		—		(51.4)
Dividends declared, $0.36 per share	—	—		—		—		(51.6)		—		(51.6)
Common stock issued	173,322	0.2		—		4.3		—		—		4.5
Common stock issued	520,494	0.6		—		(0.6)		—		—		—
Stock-settled, stock-based compensation expense	—	—		—		9.5		—		—		9.5
Repurchase of common stock and common stock withheld to cover taxes	(1629,~~591,793~~268)	—		(9240.24)		—		—		—		(9240.24)
Other	—	—		(0.63)		1.0.7		(0.36)		—		(0.12)
Comprehensive income	—	—		—		—		127.4		55.7		183.1
Comprehensive income (loss)	—	—		—		—		62.1		(19.5)		42.6
Balance at November 23, 2025	138,879,465	$	152.0	$	(897.4)	$	(453.7)	$	2,871.9	$	81.6	$	1,754.4
Balance at August 25, 2024	142,595,357	$	151.3	$	(633.7)	$	(499.0)	$	2,775.3	$	42.8	$	1,836.7
Dividends declared, $0.36 per share	—	—		—		—		(51.3)		—		(51.3)
Common stock issued	54,070	—		—		—		—		—		—
Stock-settled, stock-based compensation expense	—	—		—		12.3		—		—		12.3
Repurchase of common stock and common stock withheld to cover taxes	(8,791)	—		(0.7)		—		—		—		(0.7)
Other	—	—		—		(10.6)		(0.7)		—		(11.3)
Comprehensive loss	—	—		—		—		(36.1)		(116.8)		(152.9)
Balance at November 24, 2024	142,640,636	$	151.3	$	(634.4)	$	(497.3)	$	2,687.2	$	(74.0)	$	1,632.8


	Twenty-Six weeks ended November 23, 2025 and November 24, 2024
	Common Stock, net of Treasury Shares	Common Stock Amount		Treasury Stock Amount		Additional Paid-in (Distributed) Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity
Balance at May 25, 2025	139,237,760	$	151.4	$	(838.0)	$	(479.1)	$	2,848.9	$	54.5	$	1,737.7
Dividends declared, $0.74 per share	—	—		—		—		(103.0)		—		(103.0)
Common stock issued	615,897	0.6		—		3.9		—		—		4.5
Stock-settled, stock-based compensation expense	—	—		—		20.1		—		—		20.1
Repurchase of common stock and common stock withheld to cover taxes	(974,192)	—		(59.1)		—		—		—		(59.1)
Other	—	—		(0.3)		1.4		(0.4)		—		0.7
Comprehensive income	—	—		—		—		126.4		27.1		153.5
Balance at November 23, 2025	138,879,465	$	152.0	$	(897.4)	$	(453.7)	$	2,871.9	$	81.6	$	1,754.4

Balance at May 26, 2024	143,666,656	$	150.7	$	(540.9)	$	(508.9)	$	2,699.8	$	(12.9)	$	1,787.8
Dividends declared, $0.72 per share	—	—		—		—		(102.9)		—		(102.9)
Common stock issued	574,564	0.6		—		(0.6)		—		—		—
Stock-settled, stock-based compensation expense	—	—		—		21.8		—		—		21.8
Repurchase of common stock and common stock withheld to cover taxes	(1,600,584)	—		(92.9)		—		—		—		(92.9)
Other	—	—		(0.6)		(9.6)		(1.0)		—		(11.2)
Comprehensive income (loss)	—	—		—		—		91.3		(61.1)		30.2
Balance at November 24, 2024	142,640,636	$	151.3	$	(634.4)	$	(497.3)	$	2,687.2	$	(74.0)	$	1,632.8

See Condensed Notes to Consolidated Financial Statements.

Table of Contents

Lamb Weston Holdings, Inc.

Consolidated Statements of Cash Flows

(unaudited, dollars in millions)

	Thirteen Weeks Ended
	Twenty-Six Weeks Ended
	August 24,2025		August 25,2024
	November 23,2025		November 24,2024
Cash flows from operating activities
Net income	$	64126.34	$	~~127~~91.43
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of intangibles and debt issuance costs	95191.35		90211.50
Stock-settled, stock-based compensation expense	1020.61		921.59
Equity method investment (earnings) loss, net of distributions	0.(2.8)		(011.1)5
Deferred income taxes	1419.50		(21.9)4
Pension expense, net of contributions	1314.12		01.62
Blue chip swap transaction gains	—		(1619.69)
Other	(111.5)8		~~(15~~14.0)4
Changes in operating assets and liabilities:
Receivables	1743.68		3139.90
Inventories	~~136~~(79.35)		10(198.2)
Income taxes payable/receivable, net	22(6.85)		49(25.1)
Prepaid expenses and other current assets	4067.25		5075.12
Accounts payable	~~(47~~117.7)3		9216.58
Accrued liabilities	~~(13.~~7).6		(1411.02)
Net cash provided by operating activities	$	~~352~~530.04	$	~~330~~429.23
Cash flows from investing activities
Additions to property, plant and equipment	(77155.60)		(~~325~~474.96)
Additions to other long-term assets	(10.67)		(2631.37)
Proceeds from blue chip swap transactions, net of purchases	—		16.6
Proceeds from sale of property, plant and equipment	14.7		1.5
Other	2.9		—
Proceeds from blue chip swap transactions, net of purchases	—		19.9
Net cash used for investing activities	$	(76.3)	$	(335.6)
Other	3.7		—
Net cash used for investing activities	$	(137.3)	$	(484.9)
Cash flows from financing activities
Proceeds from short-term borrowings	~~305~~374.08		~~398~~811.06
Repayments of short-term borrowings	(~~466~~562.94)		(~~194~~813.48)
Proceeds from issuance of debt	—		3520.32
Repayments of debt and financing obligations	(1635.27)		(10245.24)
Dividends paid	(51103.73)		(51103.73)
Repurchase of common stock and common stock withheld to cover taxes	(1859.71)		(92.28)
Other	—3.9		(013.62)
Net cash (used for) provided by financing activities	$	(~~248~~381.58)	$	5263.23
Effect of exchange rate changes on cash and cash equivalents	0.7		2(0.61)
Net increase in cash and cash equivalents	2712.90		497.46
Cash and cash equivalents, beginning of period	70.7		71.4
Cash and cash equivalents, end of period	$	9882.67	$	~~120~~79.80

See Condensed Notes to Consolidated Financial Statements.

Table of Contents

Lamb Weston Holdings, Inc.

Condensed Notes to Consolidated Financial Statements

(Unaudited)

1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Lamb Weston Holdings, Inc. (“we,” “us,” “our,” the “Company,” or “Lamb Weston”) is a leading global producer, distributor, and marketer of value-added frozen potato products; headquartered in Eagle, Idaho. We have two reportable segments: North America and International. See Note 13, Segments, for additional information on our reportable segments.

Basis of Presentation

The accompanying unaudited Consolidated Financial Statements present the financial results of Lamb Weston and its consolidated subsidiaries for the thirteen and twenty-six weeks ended ~~August~~November 2423, 2025 and ~~August~~November 2524, 2024, and have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America (“U.S.”).

These consolidated financial statements are unaudited and include all adjustments that we consider necessary for a fair presentation of such financial statements and consist only of normal recurring adjustments. The preparation of financial statements involves the use of estimates and accruals. The actual results that we experience may differ materially from those estimates. Results for interim periods should not be considered indicative of results for our full fiscal year, which ends the last Sunday in May.

These financial statements and related condensed notes should be read together with the consolidated financial statements and notes in our Annual Report on Form 10-K for the fiscal year ended May 25, 2025 (the “Form 10-K”), where we include additional information on our critical accounting estimates, policies, and the methods and assumptions used in our estimates. We filed the Form 10-K with the Securities and Exchange Commission (the “SEC”) on July 23, 2025.

Certain amounts from prior period consolidated financial statements have been reclassified to conform with current period presentation. These reclassifications had no financial impact on previously reported net income, cash flows, or stockholders'’ equity.

Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, to enhance transparency and decision usefulness of income tax disclosures, particularly around rate reconciliations and income taxes paid information. ASU 2023-09 is effective for our Annual Report on Form 10-K for the fiscal year ending May 31, 2026, on a prospective basis, with early adoption permitted. We adopted this guidance as of May 26, 2025, and will update disclosures within our fiscal 2026 Annual Report on Form 10-K.

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), which requires companies to provide more detailed information of certain income statement expenses within the footnotes to the financial statements. ASU 2024-03 is effective for our Annual Report on Form 10-K for the fiscal year ending May 28, 2028, and for our quarterly reports beginning fiscal year 2029, on a prospective basis, with early adoption permitted. We are evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.

In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal - Use Software (Subtopic 350-40): Targeted Improvements to Accounting for Internal-Use Software. This guidance provides criteria that must be met for entities to capitalize software development costs and factors to consider if there is significant uncertainty associated with the development activities of software. This guidance is effective for our annual reporting periods beginning with fiscal 2029 and interim periods within that fiscal year. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.

There were no other accounting pronouncements recently issued that had or are expected to have a material impact on our consolidated financial statements.

Table of Contents

2. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per common share for the periods presented:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in millions, except per share amounts)	~~August~~November 2423,2025		~~August~~November 2524,2024		November 23,2025		November 24,2024
Numerator:
Net income	$	64.3	$	127.4
Net income (loss)	$	62.1	$	(36.1)	$	126.4	$	91.3
Denominator:
Basic weighted average common shares outstanding	139.54		~~143~~142.68		139.4		143.2
Add: Dilutive effect of employee incentive plans (a)	0.32		0.64		0.3		0.5
Diluted weighted average common shares outstanding	139.86		~~144~~143.2		139.7		143.7
Earnings per share:
Basic	$	0.4645	$	(0.8925)	$	0.91	$	0.64
Diluted	$	0.4644	$	(0.8825)	$	0.90	$	0.64

___________________________________________

(a)Potential dilutive shares of common stock under employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options and the assumed vesting of outstanding restricted stock units and performance awards. As of ~~August~~November 2423, 2025 and ~~August~~November 2524, 2024, we excluded 1.70 million and 0.86 million, respectively, of shares of stock-based awards ~~were excluded~~ from the computation of diluted earnings per share because they would be antidilutive.

3. INCOME TAXES

Income tax expense for the periods presented were as follows:

	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in millions)	~~August~~November 2423,2025		~~August~~November 2524,2024		November 23,2025		November 24,2024
Income before income taxes and equity method earnings	$	112.8	$	166.9
Income (loss) before income taxes and equity method earnings	$	94.9	$	(24.8)	$	207.7	$	142.1
Equity method investment earnings (loss)	(0.6)		11.3
Equity method investment earnings	$	3.2	$	2.1	$	2.6	$	13.4
Income tax expense	~~47.9~~$	36.0	~~50.8~~$	13.4	$	83.9	$	64.2
Effective tax rate (a)	4236.7%		28(59.50)%		39.9%		41.3%

___________________________________________

(a)The effective income tax rate is calculated as the ratio of income tax expense to pre-tax income, inclusive of equity method investment earnings. The effective tax rate varies from the U.S. statutory tax rate of 21% principally due to the impact of U.S. state taxes, foreign taxes and currency, permanent differences, and discrete items.

Compared to the thirteen weeks ended August 25, 2024, the effective tax rate is higher primarily due to having a larger proportion of losses in certain jurisdictions with no expected tax benefits. In addition, the thirteen weeks ended August 24, 2025 included $10.2 million of discrete tax expense, primarily related to the establishment of a full valuation allowance against certain international deferred tax assets.

Income Taxes Paid

Income taxes paid, net of refunds, were $969.79 million and $686.04 million during the ~~thirteen~~twenty-six weeks ended ~~August~~November 2423, 2025 and ~~August~~November 2524, 2024, respectively.

Table of Contents

4. RESTRUCTURING

~~Restructuring~~We ~~expense~~announced ~~includes~~a ~~charges~~cost ~~from~~savings program (the “Cost Savings Program,”) ~~and~~in ~~the~~July ~~Company’s~~2025 and a restructuring plan ~~announced on October 1, 2024~~ (the “Restructuring Plan”) in October 2024, (collectively referred to as the “Plans”). Items classified as “Restructuring expense” on our Consolidated Statement of Earnings that were incurred in fiscal 2026 primarily relate to the Cost Savings Program while expenses incurred in fiscal 2025 relate solely to the Restructuring Plan. We do not expect any future costs in connection with the Restructuring Plan. Costs associated with these initiatives are presented in the table below.

We expect to recognize total pre-tax cash charges of $70 million to $100 million, most of which will be ~~paid~~recognized in fiscal 2026, related to the Cost Savings Program. The charges in the ~~first~~thirteen ~~fiscal~~and ~~quarter~~twenty-six ofweeks ~~2026~~ended November 23, 2025 largely relate to professional service fees and employee severance and other one-time termination benefits related to headcount reductions. In connection with the Restructuring Plan, we have recognized $187.6 million of pre-tax charges since it was announced. We do not expect any future costs in connection with the Restructuring Plan at this time.

For the thirteen weeks ended August 24, 2025, we recorded $31.9 million of pre-tax charges related to the Plans, all of which were cash charges.


	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in millions)	November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024
Cost Savings Program and Restructuring Plan expenses related to:
Accelerated depreciation, retirement of assets, and other plant charges (a)	$	—	$	45.8	$	1.8	$	45.8
Potato contract terminations (b)	—		64.7		—		64.7
Inventory write-off (b)	—		19.8		—		19.8
Employee-related costs (c)	0.9		16.2		9.0		16.2
Professional services and other (d)	13.2		12.6		35.2		12.6
	$	14.1	$	159.1	$	46.0	$	159.1

(in millions)	Thirteen Weeks Ended August 24, 2025
Expenses related to: (a)	Restructuring Plan		Cost Savings Program		Total
Accelerated depreciation, retirement of assets, and other plant charges (b)	$	1.8	$	—	$	1.8
Employee-related costs (c)	—		8.1		8.1
Professional services and other	—		22.0		22.0
	$	1.8	$	30.1	$	31.9

___________________________________________

(a)~~These~~Includes charges ~~were~~related ~~included~~to inaccelerating ~~Cost~~depreciation of ~~sales and Restructuring expense in~~ the ~~Company’s~~manufacturing ~~Consolidated~~facility ~~Statement~~permanently ofclosed ~~Earnings.~~under ~~They are included as “unallocated corporate costs” before being reconciled in~~ the ~~Segment~~Restructuring ~~Adjusted~~Plan, ~~EBITDA~~other toasset ~~Net income table in Note 13~~retirements, ~~Segments,~~and ofplant ~~these Condensed Notes to the Consolidated Financial Statements~~charges.

(b)InIncludes the ~~thirteen~~cost ~~weeks~~of ~~ended~~contracted ~~August 24,~~raw ~~2025~~potatoes that were not used due to curtailed production and the write-off of inventories, ~~all~~including ~~expenses~~spare ~~relate~~parts, related to ~~plant~~the ~~charges~~production curtailment under the Restructuring Plan.

(c)Includes employee severance and other one-time termination benefits related to reductions in headcount under the ~~Cost Savings Program~~Plans.

~~Accruals~~(d)Includes ~~remaining~~professional ~~under~~services ~~the Plans are recorded as current liabilities within “Accounts payable”~~ and ~~“Accrued~~other ~~liabilities”~~charges inrelated to the ~~accompanying Consolidated Balance Sheet at August 24, 2025~~Plans. ~~The following is a roll-forward of restructuring activity:~~

(in millions)	Restructuring Plan		Cost Savings Program		Total
Accrued restructuring liability, May 25, 2025	$	21.5	$	—	$	21.5
Additions	1.8		30.1		31.9
Payments	(18.9)		(7.2)		(26.1)
Accrued restructuring liability, August 24, 2025	$	4.4	$	22.9	$	27.3

The following amounts related to the Plans are included within the following financial statement captions in the Company’s Consolidated Statements of Earnings:

5. INVENTORIES


	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in millions)	November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024
Cost Savings Program and Restructuring Plan expenses included in:
Cost of sales	$	—	$	75.5	$	(0.4)	$	75.5

Restructuring expense	14.1		74.6		46.4		74.6
Equity method investment earnings	—		9.0		—		9.0
	$	14.1	$	159.1	$	46.0	$	159.1

Inventories are valued at the lower of cost (determined using the first-in, first-out method) or net realizable value and include all costs directly associated with manufacturing products: materials, labor, and manufacturing overhead. The components of inventories were as follows:

(in millions)	August 24,2025		May 25,2025
Raw materials and packaging	$	127.6	$	171.5
Finished goods	668.4		755.7
Supplies and other	110.8		108.2
Inventories	$	906.8	$	1,035.4

Table of Contents

Accruals remaining under the Plans are recorded as current liabilities within “Accounts payable” and “Accrued liabilities” in the accompanying Consolidated Balance Sheet at November 23, 2025. The following is a roll-forward of accrued restructuring liabilities related to the Plans:


(in millions)	Restructuring Plan		Cost Savings Program		Total
Accrued restructuring liability, May 25, 2025	$	21.5	$	—	$	21.5
Additions	1.8		44.2		46.0
Payments	(23.3)		(32.1)		(55.4)
Accrued restructuring liability, November 23, 2025	$	—	$	12.1	$	12.1

5. INVENTORIES


(in millions)	November 23, 2025		May 25, 2025
Raw materials and packaging	$	312.5	$	171.5
Finished goods	686.1		755.7
Supplies and other	119.2		108.2
Inventories	$	1,117.8	$	1,035.4

6. PROPERTY, PLANT AND EQUIPMENT

The components of property, plant and equipment were as follows:

(in millions)

~~August~~November 2423,2025

May 25,2025

Land and land improvements

~~210~~209.21

191.6

Buildings, machinery and equipment

5,~~491~~574.96

5,136.3

Furniture, fixtures, office equipment and other

~~171~~154.05

161.9

Construction in progress

~~249~~222.73

551.7

Property, plant and equipment, at cost

6,~~122~~160.85

6,041.5

Less accumulated depreciation

(2,~~436~~507.16)

(2,353.6)

Property, plant and equipment, net

3,~~686~~652.79

3,687.9

At ~~August~~November 2423, 2025 and May 25, 2025, purchases of property, plant and equipment included in accounts payable were $5759.01 million and $85.4 million, respectively.

Below is a breakdown of depreciation and amortization between cost of sales (“COS”) and selling, general and administrative expenses (“SG&A”) for the thirteen weeks ended August 24, 2025 and August 25, 2024.

	Thirteen Weeks Ended
(in millions)	August 24,2025		August 25,2024
Depreciation - COS	$	82.8	$	78.5
Depreciation - SG&A	3.4		3.4
	$	86.2	$	81.9
Amortization	$	7.9	$	7.4

Interest capitalized within construction in progress for the thirteen weeks ended August 24, 2025 and August 25, 2024, was $5.4 million and $6.7 million, respectively.

7. GOODWILL AND OTHER IDENTIFIABLE INTANGIBLE ASSETS

The following table presents changes in goodwill balances, by segment, for the thirteen weeks ended August 24, 2025:

(in millions)	North America		International		Total
Balance at May 25, 2025	$	753.2	$	337.0	$	1,090.2
Foreign currency translation adjustment	16.3		7.2		23.5
Balance at August 24, 2025	$	769.5	$	344.2	$	1,113.7

Table of Contents

The table below presents a breakdown of depreciation and amortization between Cost of sales (“COS”) and Selling, general and administrative expense (“SG&A”) for the thirteen and twenty-six weeks ended November 23, 2025 and November 24, 2024.


	Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in millions)	November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024
Depreciation - COS	$	86.2	$	79.6	$	168.9	$	158.1
Depreciation - SG&A	3.2		3.7		6.7		7.0
Depreciation - Restructuring expense (a)	—		28.9		—		28.9
	$	89.4	$	112.2	$	175.6	$	194.0



Amortization	$	7.9	$	7.2	$	15.9	$	14.7

Interest capitalized within construction in progress for the thirteen weeks ended November 23, 2025 and November 24, 2024, was $1.6 million and $8.2 million, respectively; and $7.0 million and $14.9 million for the twenty-six weeks ended November 23, 2025 and November 24, 2024, respectively.

7. GOODWILL AND OTHER IDENTIFIABLE INTANGIBLE ASSETS

The following table presents changes in goodwill balances, by segment, for the twenty-six weeks ended November 23, 2025:


(in millions)	North America		International		Total
Balance at May 25, 2025	$	753.2	$	337.0	$	1,090.2
Foreign currency translation adjustment	6.5		2.8		9.3
Balance at November 23, 2025	$	759.7	$	339.8	$	1,099.5

Other identifiable intangible assets were as follows:

	August 24, 2025							May 25, 2025
	November 23, 2025							May 25, 2025
(in millions, except useful lives)	Weighted Average Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		IntangibleAssets, Net		Weighted Average Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		IntangibleAssets, Net
Non-amortizing intangible assets (a)	n/a	$	18.0	$	—	$	18.0	n/a	$	18.0	$	—	$	18.0
Amortizing intangible assets (b)	13	~~143~~142.81		(4749.32)		9692.59		13	140.8		(44.8)		96.0
		$	~~161~~160.81	$	(4749.32)	$	~~114~~110.59		$	158.8	$	(44.8)	$	114.0

___________________________________________

(a)Non-amortizing intangible assets represent brands and trademarks.

(b)Amortizing intangible assets are principally composed of licensing agreements, brands, and customer relationships. Foreign intangible assets are affected by foreign currency translation.

8. OTHER ASSETS

The components of other assets were as follows:

(in millions)	~~August~~November 2423,2025		May 25,2025
Capitalized software costs	$	~~199~~192.83	$	208.7
Equity method investments	4751.12		47.5
Property, plant and equipment deposits	2224.47		30.3
Other	6170.53		68.1
Other assets	$	~~330~~338.85	$	354.6

9. ACCRUED LIABILITIES

The components of accrued liabilities were as follows:

(in millions)	August 24,2025		May 25,2025
Compensation and benefits	$	102.3	$	104.5
Accrued trade promotions	98.8		88.2
Dividends payable to shareholders	51.6		51.7
Taxes payable	46.7		37.3
Accrued interest	25.1		36.3
Current portion of operating lease obligations	23.5		23.9
Plant utilities and accruals	21.5		23.0
Derivative liabilities and payables	6.4		7.0
Other	40.0		39.1
Accrued liabilities	$	415.9	$	411.0

Table of Contents

9. ACCRUED LIABILITIES

The components of accrued liabilities were as follows:


(in millions)	November 23, 2025		May 25, 2025
Compensation and benefits	$	120.1	$	104.5
Accrued trade promotions	97.1		88.2
Dividends payable to shareholders	51.4		51.7
Accrued interest	35.0		36.3
Taxes payable	27.2		37.3
Current portion of operating lease obligations	26.1		23.9
Plant accruals	20.4		23.0
Derivative liabilities and payables	6.1		7.0
Other	40.8		39.1
Accrued liabilities	$	424.2	$	411.0

10. DEBT AND FINANCING OBLIGATIONS

The components of our debt, including financing obligations, were as follows:

(in millions)	~~August~~November 2423, 2025				May 25, 2025
	Amount		Interest Rate		Amount		Interest Rate
Short-term borrowings:
Revolving credit facility	$	~~181~~149.67	43.~~100~~830	%	$	333.2	5.940	%
Other credit facilities (a)	3337.83				37.6
	215.4				370.8
	187.0				370.8
Long-term debt:
Term A-3 loan facility, due January 2030 (b)	~~399~~393.38		6.~~430~~350		405.0		6.900
Term A-4 loan facility, due May 2029 (b)	~~308~~304.87		6.690		312.8		6.630
Term A-5 loan facility, due September 2031 (b)	~~487~~481.53		5.660		493.8		5.650
RMB loan facility, due February 2027	~~144~~142.02		3.800		143.8		4.040
RMB loan facility, due September 2029	19.7		3.800		19.6		3.960
Euro term loan facility, due May 2029	~~234~~230.3		3.~~500~~440		227.2		4.510
4.875% senior notes, due May 2028	500.0		4.875		500.0		4.875
4.125% senior notes, due January 2030	970.0		4.125		970.0		4.125
4.375% senior notes, due January 2032	700.0		4.375		700.0		4.375
	3,763.6				3,772.2
	3,742.0				3,772.2
Financing obligations:
Lease financing obligations due on various dates through 2040	4.95				5.2
Total debt and financing obligations	3,~~983~~933.95				4,148.2
Debt issuance costs (c)	(1514.89)				(16.8)
Short-term borrowings	(~~215~~187.40)				(370.8)
Current portion of long-term debt and financing obligations	(8182.87)				(77.8)
Long-term debt and financing obligations, excluding current portion	$	3,~~670~~648.9			$	3,682.8

___________________________________________

Table of Contents

(a)Other credit facilities consist of short-term facilities at our subsidiaries used for working capital purposes. Borrowings under these facilities bear interest at various rates.

(b)The interest rates applicable to the Term A-3, A-4, and A-5 loans do not include anticipated patronage dividends. We have received and expect to continue receiving patronage dividends under these term loan facilities.

(c)Excludes debt issuance costs of $3.74 million and $3.9 million as of ~~August~~November 2423, 2025 and May 25, 2025, respectively, related to our Revolving credit facility, which are recorded in “Other assets” on our Consolidated Balance Sheets.

As of ~~August~~November 2423, 2025, we had $1,~~318~~350.43 million of available liquidity under our committed revolving credit facility.

For the ~~thirteen~~twenty-six weeks ended ~~August~~November 2423, 2025 and ~~August~~November 2524, 2024, we paid $62100.35 million and $5697.71 million of interest on debt, respectively.

For more information about our debt and financing obligations, interest rates, and debt covenants, see Note 8, Debt and Financing Obligations, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and Supplementary Data” of the Form 10-K.

Table of Contents

11. FAIR VALUE MEASUREMENTS

The fair values of cash equivalents, receivables, accounts payable, and short-term debt approximate their carrying amounts due to their short duration.

The following table presents our financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall:

	As of August 24, 2025
	As of November 23, 2025
(in millions)	Level 1		Level 2		Level 3		Fair Valueof Assets(Liabilities)
Derivative assets (a)	$	—	$	~~16.~~2.8	$	—	$	~~16.~~2.8
Derivative liabilities (a)	—		(6.41)		—		(6.41)
Deferred compensation liabilities (b)	—		(2930.50)		—		(2930.50)
Fair value, net	$	—	$	(1933.73)	$	—	$	(1933.73)


	As of May 25, 2025
(in millions)	Level 1		Level 2		Level 3		Fair Value of Assets (Liabilities)

Derivative assets (a)	$	—	$	10.2	$	—	$	10.2
Derivative liabilities (a)	—		(7.0)		—		(7.0)
Deferred compensation liabilities (b)	—		(27.0)		—		(27.0)
Fair value, net	$	—	$	(23.8)	$	—	$	(23.8)

___________________________________________

(a)Derivative assets and liabilities included in Level 2 primarily represent commodity swaps, option contracts, interest rate ~~swap~~swaps and currency contracts. The fair value of these derivatives were determined using valuation models that use market observable inputs including both forward and spot prices. Derivative assets are presented within “Prepaid expenses and other current assets” on our Consolidated Balance Sheets and derivative liabilities are presented within “Accrued liabilities” on our Consolidated Balance Sheets.

(b)The fair values of our Level 2 deferred compensation liabilities were valued using third-party valuations, which are based on the net asset values of mutual funds in our retirement plans. While the underlying assets are actively traded on an exchange, the funds are not. Deferred compensation liabilities are primarily presented within “Other noncurrent liabilities” on our Consolidated Balance Sheets.

As of August 24, 2025, we had $2,966.3 million of fixed-rate and $1,012.7 million of variable-rate debt outstanding. Based on current market rates, the fair value of our fixed-rate debt was estimated to be $2,888 million as of August 24, 2025. Any differences between the book value and fair value are due to the difference between the period-end market interest rate and the stated rate of our fixed-rate debt. The fair value of our variable-rate term debt approximates the carrying amount and approximates current market prices.14

Table of Contents

As of November 23, 2025, we had $2,956.0 million of fixed-rate and $973.0 million of variable-rate debt outstanding. Based on current market rates, the fair value of our fixed-rate debt was estimated to be $2,885 million as of November 23, 2025. Any differences between the book value and fair value are due to the difference between the period-end market interest rate and the stated rate of our fixed-rate debt. The fair value of our variable-rate term debt approximates the carrying amount and approximates current market prices.

12. STOCKHOLDERS’ EQUITY

Share Repurchase Program

Our Board of Directors (the “Board”) has authorized a program, with no expiration date, to repurchase up to $750.0 million of our common stock. During the thirteen weeks ended ~~August~~November 2423, 2025, we repurchased ~~187~~617,~~259~~623 shares of our common stock for an aggregate purchase price of $1039.46 million, or a weighted-average price of $5564.3418 per share. During the twenty-six weeks ended November 23, 2025, we repurchased 804,882 shares of our common stock for an aggregate purchase price of $50.0 million, or a weighted-average price of $62.12 per share. As of ~~August~~November 2423, 2025, approximately $~~348~~308 million remained authorized for repurchase under our share repurchase program.

Dividends

During the ~~thirteen~~twenty-six weeks ended ~~August~~November 2423, 2025, we paid $51103.73 million of cash dividends to our common stockholders. In addition, on ~~August 29~~November 28, 2025, we paid $51.64 million of cash dividends to common stockholders of record as of the close of business on ~~August 1~~October 31, 2025. On ~~September~~December 2517, 2025, the Board declared a cash dividend of $0.3738 per share of our common stock. This dividend will be paid on February 27, 2026, to common stockholders of record as of the close of business on January 30, 2026.

14Accumulated Other Comprehensive Income

~~Table~~Changes in accumulated other comprehensive income, net of ~~Contents~~taxes, as of November 23, 2025 were as follows:

share of our common stock. This dividend will be paid on November 28, 2025, to common stockholders of record as of the close of business on October 31, 2025.


(in millions)	Foreign Currency Translation Gain		Pension and Post-Retirement Benefits		Other		Accumulated Other Comprehensive Income
Balance as of May 25, 2025	$	58.9	$	(4.6)	$	0.2	$	54.5
Other comprehensive income before reclassifications, net of tax	21.9		5.2		—		27.1
Net current-period other comprehensive income	21.9		5.2		—		27.1
Balance as of November 23, 2025	$	80.8	$	0.6	$	0.2	$	81.6

Accumulated Other Comprehensive Income (Loss)

Changes in accumulated other comprehensive income, net of taxes, as of August 24, 2025 were as follows:

(in millions)	ForeignCurrency Translation Gain (Loss)		Pension and Post-RetirementBenefits		Other		AccumulatedOtherComprehensiveIncome (Loss)
Balance as of May 25, 2025	$	58.9	$	(4.6)	$	0.2	$	54.5
Other comprehensive income before reclassifications, net of tax	41.3		5.3		—		46.6
Net current-period other comprehensive income	41.3		5.3		—		46.6
Balance as of August 24, 2025	$	100.2	$	0.7	$	0.2	$	101.1

13. SEGMENTS

We manage our operations in two business segments, North America and International. As a result of how we manage the business, we have two operating segments, each of which is a reportable segment: North America and International. North America includes activity that occurs in the United States, Canada, and Mexico. International includes all activity that does not occur within the North America segment. Both segments primarily manufacture frozen potato products for sale to our customers. These reportable segments are each managed by a general manager and supported by a cross -functional team assigned to support the segment.

Our president and chief executive officer is our chief operating decision maker (the “CODM”). The CODM assesses the performance of our reportable segments and decides how to allocate resources based on segment adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”). The adjustments to EBITDA include unrealized mark-to-market derivative gains and losses (which are a component of both cost of sales and selling, general and administrative expenses), foreign currency exchange gains and losses (which are a component of selling, general and administrative expenses), blue chip swap transaction gains (which are a component of selling, general and administrative expenses), stock-based compensation (which is a component of selling, general and administrative expenses), and other items impacting comparability (which are a component of both cost of sales and selling, general and administrative expenses) that are described below (“Segment Adjusted EBITDA”).

Net sales and Segment Adjusted EBITDA inform operating decisions, performance assessment, and resource allocation decisions at the segment level. Our CODM uses net sales and Segment Adjusted EBITDA in the annual operating plan and forecasting process and considers actual versus plan variances in assessing the performance of each segment. Total asset information by segment is not regularly provided to our CODM or utilized for purposes of assessing performance or allocating resources by segment and, as a result, such information has not been presented below.

Table of Contents

~~The~~Net ~~following~~sales ~~table~~and ~~illustrates~~Segment ~~reportable~~Adjusted EBITDA inform operating decisions, performance assessment, and resource allocation decisions at the segment level. Our CODM uses net sales and Segment Adjusted EBITDA ~~for~~in the ~~thirteen~~annual ~~weeks~~operating ~~ended~~plan ~~August 24,~~and ~~2025~~forecasting process and ~~August 25~~considers actual versus plan variances in assessing the performance of each segment. Total asset information by segment is not regularly provided to our CODM or utilized for purposes of assessing performance or allocating resources by segment and, ~~2024~~as a result, ~~respectively~~such information has not been presented below.

	Thirteen Weeks Ended
	August 24,2025						August 25,2024
(in millions)	North America		International		Total		North America		International		Total
Net Sales	$	1,084.6	$	574.7	$	1,659.3	$	1,103.7	$	550.4	$	1,654.1
Other segment items (a)	824.6		517.5		1,342.1		825.7		499.0		1,324.7
Segment Adjusted EBITDA (b)	$	260.0	$	57.2	$	317.2	$	278.0	$	51.4	$	329.4
Unallocated corporate costs (c)					(15.0)						(30.0)
Depreciation and amortization (d)					96.3						91.4
Unrealized derivative gains					(4.9)						(8.9)
Foreign currency exchange losses					(4.7)						0.6
Blue chip swap gains (e)					—						(16.6)
Stock-based compensation					10.6						9.5
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses (f)					31.9						—
Shareholder activism expense (g)					4.0						—
Pension settlement (h)					13.1						—
Interest expense, net					43.7						45.2
Income before income taxes					112.2						178.2
Income tax expense					47.9						50.8
Net income					$	64.3					$	127.4

The following table illustrates reportable segment net sales and Segment Adjusted EBITDA for the thirteen and twenty-six weeks ended November 23, 2025 and November 24, 2024, respectively.


	Thirteen Weeks Ended
	November 23, 2025						November 24, 2024
(in millions)	North America		International		Total		North America		International		Total
Net Sales	$	1,069.5	$	548.6	$	1,618.1	$	1,072.1	$	528.8	$	1,600.9
Other segment items (a)	781.7		521.4		1,303.1		802.9		480.2		1,283.1
Segment Adjusted EBITDA	$	287.8	$	27.2	$	315.0	$	269.2	$	48.6	$	317.8

Unallocated corporate costs (b)					(29.3)						(23.6)
Depreciation and amortization (c)					99.7						92.5
Unrealized derivative gains					12.1						3.0
Foreign currency exchange losses					6.8						9.6
Blue chip swap gains (d)					—						(3.3)
Stock-based compensation					9.5						12.3
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses (e)					14.1						159.1
Shareholder activism expense (f)					—						0.4
Pension settlement (g)					1.1						—
Interest expense, net					44.3						43.3
Income before income taxes					98.1						(22.7)
Income tax expense					36.0						13.4
Net income (loss)					$	62.1					$	(36.1)

___________________________________________

(a)Other segment items include cost of sales, selling, general, and administrative expenses, and equity method investment income or loss for each segment.

(b)Unallocated corporate costs include costs related to corporate support staff and support services, which include, but are not limited to, our administrative, information technology, human resources, finance, and accounting functions that are not specifically allocated to the segments. In the table, unallocated corporate costs exclude unrealized derivative gains and losses, foreign currency exchange gains and losses, blue chip swap transaction gains, and other items impacting comparability. These items are added back to reconcile Segment Adjusted EBITDA ~~includes~~to ~~the~~net ~~following:~~income.

~~i.Net~~(c)Depreciation and amortization includes interest expense, income ~~(loss)~~tax ~~associated~~expense, ~~with~~and ~~our~~depreciation and amortization relating to equity method investments of $2.2 million and $2.0 million for the thirteen weeks ended November 23, 2025 and November 24, 2024, respectively.

~~ii.For~~(d)We ~~the~~entered ~~thirteen~~into ~~weeks~~blue ~~ended~~chip ~~August 25,~~swap ~~2024,~~transactions anto ~~estimated~~transfer ~~$39~~U.S. ~~million~~dollars ~~loss~~into Argentina primarily related to afunding ~~voluntary~~our ~~product~~capacity ~~withdrawal~~expansion ~~that was initiated~~ in ~~the~~Argentina, ~~fourth~~which ~~quarter~~is ofnow ~~fiscal~~substantially ~~2024~~complete. The ~~total~~blue ~~charge~~chip toswap ~~reporting~~rate ~~segments~~can ~~was~~diverge ~~approximately~~significantly ~~$21~~from ~~million~~Argentina’s toofficial ~~the~~exchange ~~North America segment and approximately $18 million to the International segment~~rate.

(ce)~~Unallocated~~Cost ~~corporate~~Savings ~~costs include costs related to corporate support staff and support services~~Program, ~~which~~Restructuring ~~include~~Plan, ~~but~~and ~~are~~other ~~not~~expenses ~~limited~~relate to, ~~our~~costs ~~administrative,~~incurred ~~information~~under ~~technology, human resources, finance, and accounting functions that are not specifically allocated to~~ the ~~segments~~Plans. InSee ~~the~~Note ~~table~~4, ~~unallocated corporate costs exclude unrealized derivative gains and losses~~Restructuring, ~~foreign~~of ~~currency~~these ~~exchange~~Condensed ~~gains~~Notes ~~and losses, blue chip swap transaction gains, and items impacting comparability. These items are added back~~ to ~~reconcile~~Consolidated ~~Segment~~Financial ~~Adjusted~~Statements ~~EBITDA~~for toadditional ~~net income.~~information

(df)~~Depreciation~~Represents ~~and~~advisory ~~amortization~~fees ~~includes~~related ~~interest~~to ~~expense,~~shareholder ~~income~~activism ~~tax expense, and depreciation and amortization from equity method investments of $2~~matters.~~2 million and $2.1 million for the thirteen weeks ended August 24, 2025 and August 25, 2024, respectively.~~

(eg)WeThe ~~entered~~Pension ~~into~~settlement ~~blue~~charge ~~chip~~was ~~swap transactions~~ to ~~transfer~~fully ~~U.S.~~fund ~~dollars~~the ~~into~~Company’s ~~Argentina~~defined ~~primarily~~benefit ~~related~~pension toplan, ~~funding~~enabling ~~our~~lump ~~capacity~~sum ~~expansion~~payments into ~~Argentina,~~participants ~~which~~and istransferring ~~now~~the ~~substantially~~remaining ~~complete.~~obligations ~~The~~and ~~blue~~related ~~chip~~plan ~~swap~~assets ~~rate~~to ~~can~~an ~~diverge~~insurer ~~significantly~~through ~~from~~a ~~Argentina's~~group ~~official~~annuity ~~exchange rate~~contract.

(f)Cost Savings Program, Restructuring Plan, and other expenses relate to costs related to implementing the Plans. See Note 4, Restructuring, of these Condensed Notes to Consolidated Financial Statements for additional information16

Table of Contents


	Twenty-Six Weeks Ended
	November 23, 2025						November 24, 2024
(in millions)	North America		International		Total		North America		International		Total
Net Sales	$	2,154.0	$	1,123.3	$	3,277.3	$	2,175.8	$	1,079.2	$	3,255.0
Other segment items (a)	1,606.2		1,038.9		2,645.1		1,628.6		979.2		2,607.8
Segment Adjusted EBITDA (b)	$	547.8	$	84.4	$	632.2	$	547.2	$	100.0	$	647.2

Unallocated corporate costs (c)					(44.4)						(53.6)
Depreciation and amortization (d)					195.9						183.9
Unrealized derivative gains and losses					7.2						(5.9)
Foreign currency exchange losses					2.1						10.2
Blue chip swap gains (e)					—						(19.9)
Stock-based compensation					20.1						21.8
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses (f)					46.0						159.1
Shareholder activism expense (g)					4.0						0.4
Pension settlement (h)					14.2						—
Interest expense, net					88.0						88.5
Income before income taxes					210.3						155.5
Income tax expense					83.9						64.2
Net income					$	126.4					$	91.3

___________________________________________

(a)Other segment items include cost of sales, selling, general and administrative expenses, and equity method investment income or loss for each segment.

(b)Segment Adjusted EBITDA for the twenty-six weeks ended November 24, 2024 includes an estimated $39 million loss related to a voluntary product withdrawal that was initiated in the fourth quarter of fiscal 2024. The total charge to reporting segments was approximately $21 million to the North America segment and approximately $18 million to the International segment.

(c)Unallocated corporate costs include costs related to corporate support staff and support services, which include, but are not limited to, our administrative, information technology, human resources, finance, and accounting functions that are not specifically allocated to the segments. In the table, unallocated corporate costs exclude unrealized derivative gains and losses, foreign currency exchange gains and losses, blue chip swap transaction gains, and other items impacting comparability. These items are added back to reconcile Segment Adjusted EBITDA to net income.

(d)Depreciation and amortization includes interest expense, income tax expense, and depreciation and amortization relating to equity method investments of $4.4 million and $4.1 million for the twenty-six weeks ended November 23, 2025 and November 24, 2024, respectively.

(e)We entered into blue chip swap transactions to transfer U.S. dollars into Argentina primarily related to funding our capacity expansion in Argentina, which is now substantially complete. The blue chip swap rate can diverge significantly from Argentina’s official exchange rate.

(f)Cost Savings Program, Restructuring Plan, and other expenses relate to costs incurred under the Plans. See Note 4, Restructuring, of these Condensed Notes to Consolidated Financial Statements for additional information

(g)Represents advisory fees related to shareholder activism matters.

(h)The Pension settlement charge was to fully fund the Company’s defined benefit pension plan, enabling lump sum payments to participants and transferring the remaining obligations and related plan assets to an insurer through a group annuity contract.

1617

Table of Contents

14. COMMITMENTS, CONTINGENCIES, GUARANTEES AND LEGAL PROCEEDINGS

We have financial commitments and other obligations that arise in the ordinary course of our business. These include long-term debt, lease obligations, and purchase commitments for goods and services. There have been no material changes to the commitments, contingencies, and guarantees disclosed in Note 14, Commitments, Contingencies, Guarantees, and Legal Proceedings, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and Supplementary Data” of the Form 10-K.

Legal Proceedings

In June 2024, two putative class actions were filed in the U.S. District Court for the District of Idaho against the Company and certain of our current and former executive officers alleging violations of the federal securities laws. The lawsuits were consolidated in November 2024. The amended consolidated complaint alleges the defendants made misrepresentations and omissions regarding the design and implementation of our enterprise resource planning system and the Company’s pricing practices. The complaint asserts claims on behalf of a proposed class of purchasers of the Company’s common stock between July 25, 2023 and December 19, 2024. On April 25, 2025, defendants filed a motion to dismiss. Briefing is complete but no hearing date has been set. In June 2025, a purported Company stockholder filed a verified stockholder derivative complaint (nominally on behalf of the Company) against certain of our current and former directors and officers, alleging violations of the federal securities laws and breach of fiduciary duty stemming from the same or similar purported misrepresentations and omissions regarding the design and implementation of our enterprise resource planning system as the putative class actions. The derivative lawsuit has been stayed pending resolution of the motion to dismiss in the securities class action. We believe the lawsuits lack merit and intend to vigorously defend against the allegations. We are currently unable to predict the outcome of this matter or estimate the range of potential loss, if any, that may result.

In November 2024, a class action complaint was filed in the U.S. District Court for the Northern District of Illinois against the Company, certain of our subsidiaries and a number of other producers of frozen potato products alleging violations of antitrust laws. Additional class action complaints were later filed in the same court, based on similar allegations, bringing antitrust claims on behalf of putative classes of direct purchasers, commercial and institutional indirect purchasers, and end-consumer indirect purchasers. Some complaints ~~name~~named aadditional ~~data~~defendants. ~~provider~~The complaints were ordered to be consolidated and aamended. ~~trade~~On ~~association~~October as6, ~~defendants~~2025, inplaintiffs ~~addition~~filed tothree consolidated complaints on behalf of their putative classes, asserting amended claims against the Company, certain of our subsidiaries, other producers of frozen potato products, and a data provider. The consolidated complaints allege, among other things, that beginning at least as early as January 1, 2021, the defendants conspired to raise the price of frozen potato products above competitive levels in violation of U.S. antitrust laws by coordinating prices of frozen potato products and imposing lockstep price increases, allegedly facilitated by the exchange of non-public information about prices and production. The complaints on behalf of the putative classes of indirect purchasers also assert claims under various state laws, including state antitrust laws, unfair competition laws, and consumer protection statutes~~, and common law unjust enrichment~~. The relief sought in the complaints includes treble damages, injunctive relief, equitable monetary relief, pre- and post-judgment interest, costs and attorneys’ fees. ~~The~~On ~~complaints~~December ~~for~~5, ~~each~~2025, ~~putative~~defendants ~~class~~filed ~~have~~a ~~been~~motion ~~ordered~~ to bedismiss. ~~consolidated~~Briefing is ongoing and ~~amended~~the motion remains pending. Class actions based on similar allegations have also been filed in Canada, in the Supreme Court of British Columbia and the Superior Court of Quebec. We believe these complaints lack merit and intend to vigorously defend against the allegations. ~~Given~~We ~~the preliminary stage of the proceedings, we~~ are currently unable to predict the outcome of this matter or estimate the range of potential loss, if any, that may result.

We are also a party to various other legal actions arising in the ordinary course of our business. These claims, legal proceedings and litigation principally arise from alleged casualty, product liability, employment, and other disputes. In determining loss contingencies, we consider the likelihood of loss as well as the ability to reasonably estimate the amount of such loss or liability. An estimated loss is recognized when it is considered probable that a liability has been incurred and when the amount of loss can be reasonably estimated. While any claim, proceeding or litigation has an element of uncertainty, we believe the outcome of any of these that are pending or threatened will not have a material adverse effect on our financial condition, results of operations, or cash flows.

1718

Table of Contents

ITEM 2. MANAGEMENT'’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations, which we refer to as “MD&A,” should be read in conjunction with our condensed consolidated financial statements and related notes included in “Financial Information” of this Quarterly Report on Form 10-Q (this “Form 10-Q”) and in “Financial Statements and Supplementary Data” of the Company'’s Annual Report on Form 10-K for the fiscal year ended May 25, 2025 (the “Form 10-K”), which we filed with the United States (“U.S.”) Securities and Exchange Commission (the “SEC”) on July 23, 2025.

Forward-Looking Statements

This report, including the MD&A, contains forward-looking statements within the meaning of the federal securities laws. Words such as “~~will~~believe,” “~~continue~~enable,” “~~may~~expand,” “~~expect~~drive,” “~~anticipate~~execute,” “~~believe,” “~~strengthen,” “~~innovate~~deliver,” “~~reduce~~anticipate,” “~~estimate~~will,” “~~deliver~~continue,” “~~remain~~expect,” “~~drive~~may,” “~~increase~~reduce,” “~~expand~~estimate,” “~~focus~~remain,” “decline,” “outlook,” and variations of such words and similar expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, statements regarding our business and financial outlook and prospects, our plans and strategies and anticipated benefits therefrom, including with respect to the Cost Savings Program and Restructuring Plan, anticipated capital expenditures, ~~and~~ investments, and other costs, cash flows, liquidity, dividends, ~~and~~ anticipated conditions in our industry and the global economy. These forward-looking statements are based on management’s current expectations and are subject to uncertainties and changes in circumstances. Readers of this report should understand that these statements are not guarantees of performance or results. Many factors could affect these forward-looking statements and our actual financial results and cause them to vary materially from the expectations contained in the forward-looking statements, including those set forth in this report. These risks and uncertainties include, among other things: consumer preferences, including restaurant traffic in North America and our international markets, and an uncertain general economic environment, including as a result of tariffs and other trade policies, inflationary pressures and recessionary concerns, any of which could adversely impact our business, financial condition or results of operations, including as a result of impacts on the demand and prices for our products; the availability and prices of raw materials and other commodities; operational challenges; our ability to successfully implement the Cost Savings Program, the Restructuring Plan or other cost savings or efficiency initiatives, including achieving the benefits of those activities and possible changes in the size and timing of related charges; difficulties, disruptions or delays in implementing new technology; levels of labor and people-related expenses; our ability to successfully execute our long-term value creation strategies, including our Focus to Win plan; our ability to execute on large capital projects, including construction of new production lines or facilities; the competitive environment and related conditions in the markets in which we operate; political and economic conditions in the countries in which we conduct business and other factors related to our international operations; disruptions in the global economy caused by conflicts such as the war in Ukraine and conflicts in the Middle East and the possible related heightening of our other known risks; the ultimate outcome of litigation or any product recalls or withdrawals; changes in our relationships with our growers or significant customers; impacts on our business due to health pandemics or other contagious outbreaks, such as the COVID-19 pandemic, including impacts on demand for our products, increased costs, disruption of supply, other constraints in the availability of key commodities and other necessary services or restrictions imposed by public health authorities or governments; disruption of our access to export mechanisms; risks associated with integrating acquired businesses; risks associated with other possible acquisitions; our debt levels; actions of governments and regulatory factors affecting our businesses; our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; and other risks described in our reports filed from time to time with the SEC. We caution readers not to place undue reliance on any forward-looking statements included in this report, which speak only as of the date of this report. We undertake no responsibility for updating these statements, except as required by law.

Overview

Lamb Weston Holdings, Inc. (“we,” “us,” “our,” the “Company,” or “Lamb Weston”) is a leading global producer, distributor, and marketer of value-added frozen potato products. We are the number one supplier of value-added frozen potato products in North America and a leading supplier of value-added frozen potato products internationally, with a strong and growing presence in high-growth emerging markets. We offer a broad product portfolio to a diverse channel and customer base in over 100 countries. French fries represent the majority of our value-added frozen potato product portfolio.

Table of Contents

This MD&A is provided as a supplement to the consolidated financial statements and related condensed notes included elsewhere herein to help provide an understanding of our financial condition, changes in financial condition and results of our operations. Our MD&A is based on financial data derived from the financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). We have also presented Adjusted EBITDA, Adjusted Gross Profit, Adjusted Selling, General and Administrative expenses (“SG&A”), and Adjusted Income Tax Expense, each of which is considered a non-GAAP financial measure, to supplement the financial information included in this report. Refer to “Non-GAAP Financial Measures” below for the definitions of Adjusted EBITDA, Adjusted Gross Profit, Adjusted SG&A, and Adjusted Income Tax Expense and a reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, net income, gross profit, SG&A, or income tax expense, as applicable. For more information, refer to the “Results of Operations” and “Non-GAAP Financial Measures” sections below.

Executive Summary

During the quarter, we saw volume growth and positive customer momentum. While the operating environment remains competitive, we believe our disciplined execution and strategic plans are better enabling us to expand our customer base and drive long-term growth. We are focused on executional excellence, including delivering our Cost Savings Program. Actions taken over the past two fiscal years have improved our manufacturing costs per pound and lowered SG&A. We are focused on strengthening customer partnerships and innovating across our business.

Our operational improvements also drove favorable working capital changes, primarily from lower inventories. Operating cash flow and cash on hand increased at the end of the period, and capital expenditures declined as we near completion of our growth-related investments in our production facilities, with the startup of a new production facility in Argentina during the first quarter.

Outlook

In fiscal 2026, we anticipate that global consumers will continue to face macroeconomic and geopolitical pressures, alongside a competitive environment, particularly in our international markets. We expect global restaurant traffic to remain roughly in line with fiscal 2025 levels. We believe customers and consumers will continue to prioritize french fries both on menus and at home. Momentum from customer wins in the second half of fiscal 2025 and the contribution of a 53rd week in fiscal 2026, with the additional week falling in the fourth quarter, is expected to drive increased sales volumes.

We expect earnings will decline as they are pressured by the impact of pricing and mix, higher overall input costs, net of the benefit of lower raw potato costs, incremental depreciation and start-up costs from the capacity expansions in the Netherlands and Argentina, and increased compensation and benefits as incentive programs normalize. These factors will only be partially offset by benefits from the Restructuring Plan and Cost Savings Program.

Our outlook includes our current view of the anticipated impact of enacted tariffs by the U.S. and other governments but does not include the potential effects of evolving trade policies, including future changes in tariffs or retaliatory countermeasures.

Table of Contents

This MD&A is provided as a supplement to the consolidated financial statements and related condensed notes included elsewhere herein to help provide an understanding of our financial condition, changes in financial condition and results of our operations. Our MD&A is based on financial data derived from the financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). We have also presented Adjusted EBITDA, Adjusted Gross Profit, Adjusted Selling, General and Administrative expenses (“SG&A”), Adjusted Income Tax Expense, and Adjusted Equity Method Investment Earnings, each of which is considered a non-GAAP financial measure, to supplement the financial information included in this report. Refer to “Non-GAAP Financial Measures” below for the definitions of Adjusted EBITDA, Adjusted Gross Profit, Adjusted SG&A, Adjusted Income Tax Expense, and Adjusted Equity Method Investment Earnings and a reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, net income, gross profit, SG&A, income tax expense, or equity method investment earnings, as applicable. For more information, refer to the “Results of Operations” and “Non-GAAP Financial Measures” sections below.

Executive Summary

Our second quarter results reflect continued momentum and share gains, notably in North America and Asia. Volume increased 8% in the second quarter and 7% for the first half of the year. In response, we have restarted curtailed North American production lines. However, the global operating environment remains competitive and restaurant traffic remains down in key markets and channels. In fiscal 2026, we anticipate that global consumers will continue to face macroeconomic and geopolitical pressures, and we will be operating in a competitive environment. We believe our disciplined execution and strategic plans are better enabling us to expand our customer base and position us to drive long-term growth.

Lamb Weston’s global teams are executing our strategy, strengthening our customer relationships, driving cost savings and delivering strong cash flow. Actions taken over the past two fiscal years have improved our manufacturing costs per pound and lowered SG&A.

Results of Operations

Thirteen Weeks Ended ~~August~~November 2423, 2025 compared to Thirteen Weeks Ended ~~August~~November 2524, 2024

Net Sales and Segment Adjusted EBITDA

Thirteen Weeks Ended

(in millions, except percentages)

~~August~~November 2423,2025

~~August~~November 2524,2024

%Increase (Decrease)

% Increase (Decrease) at Constant Currency

Segment net sales

North America

1,~~084~~069.65

1,~~103~~072.71

~~(2)~~—%

International

~~574~~548.76

~~550~~528.48

—(1)%

1,~~659~~618.31

1,~~654~~600.19

—1%

~~(1)~~—%

Segment Adjusted EBITDA

North America

~~260~~287.08

~~278~~269.02

~~(6)~~7%

~~(6)%~~

International

5727.2

5148.46

11(44)%

Net Sales

Net sales for the ~~first~~second quarter of fiscal 2026 increased $517.2 million to $1,~~659~~618.31 million compared to the prior year quarter, ~~including~~and included a favorable foreign currency impact of $2324.74 million. Net sales at constant currency ~~declined~~was 1%essentially flat over the prior year quarter, as aan 68% increase in volume was ~~more than~~ offset by aan 78% decline in price/mix. Net sales and price/mix at constant currency are calculated by translating financial data for the current year period at prior year average exchange rates. Volume growth was driven by customer wins, share gains and retention, particularly in North America and Asia,. asThe ~~well~~decline ~~as lapping an approximately $15 million charge~~ in ~~the prior year quarter related to a voluntary product withdrawal. Price~~price/mix reflects ~~the~~ongoing ~~carryover~~support ~~impact~~ of ~~fiscal~~customers ~~2025~~through price and trade, ~~investments~~including tothe ~~support~~carryover ~~customers,~~impact ~~ongoing~~of ~~price~~fiscal ~~and~~2025 ~~trade support~~pricing, ~~and~~in ~~unfavorable~~a ~~channel~~competitive ~~product~~global ~~mix~~market ~~within our segments~~environment.

North America segment net sales, which includes all sales to customers in the U.S., Canada, and Mexico, declined $19.1 million, or 2%, to $1,084.6 million. Volume increased 5% compared to the prior year quarter supported by recent customer contract wins and growth across channels. Price/mix declined 7%, driven by the carryover impact from fiscal 2025 price investments, the ongoing support of customers through price and trade and an unfavorable channel mix.20

~~International~~Table ~~segment net sales, which includes all sales to customers outside~~ of North America, increased $24.3 million, or 4%, to $574.7 million year-over-year, including a favorable $24.5 million from foreign currency translation. Net sales at constant currency was flat. Volume increased 6%, led primarily by growth in Asia and with multinational chain customers. Price/mix at constant currency declined 6%, driven by investments to support customers as well as ongoing price and trade support.Contents

North America segment net sales, which includes all sales to customers in the U.S., Canada, and Mexico, was essentially flat, declining $2.6 million to $1,069.5 million. Volume increased 8% compared to the prior year quarter driven by recent customer contract wins, share gains and growth across channels. In response, we have restarted curtailed North American production lines. Price/mix declined 8%, driven by the ongoing support of customers through price and trade, including the carryover impact from fiscal 2025 pricing, and an unfavorable mix.

International segment net sales, which includes all sales to customers outside of North America, increased $19.8 million, or 4%, to $548.6 million over the prior year quarter, including a favorable $22.6 million from foreign currency translation. Net sales at constant currency declined 1%, or $2.8 million compared to the prior year quarter. Volume increased 7%, driven by growth in Asia and with multinational chain customers. Price/mix at constant currency declined 8%, reflecting ongoing price and trade to support customers in a continued competitive environment, as well as an unfavorable mix.

Gross Profit

Gross profit ~~declined~~increased $1346.65 million versus the prior year quarter to $~~342~~324.43 million. Adjusted Gross Profit declined $1415.26 million versus the prior year quarter to $~~338~~327.9 million due primarily to unfavorable price/mix. ~~Unfavorable~~Total ~~price/mix~~manufacturing cost per pound was ~~partially~~lower, ~~offset~~reflecting bythe ~~higher~~benefits ~~sales~~from ~~volumes,~~cost ~~lower~~savings ~~manufacturing~~initiatives ~~costs~~and ~~per~~improved ~~pound~~operating ~~driven~~efficiencies byin ~~cost~~our ~~savings~~North America segment. These initiatives, ~~and~~more ~~the~~than ~~benefit~~offset ofinflationary ~~lapping~~pressures anin ~~approximately~~key ~~$39~~input ~~million~~categories ~~charge~~other than raw product and higher manufacturing costs per pound in ~~the~~our ~~prior~~International ~~year~~segment, ~~related~~due to aless ~~voluntary~~favorable ~~product~~operating ~~withdrawal~~conditions and elevated production expenses.

Selling, General and Administrative Expenses

SG&A ~~increased~~declined $913.7 million versus the prior year quarter to $~~153~~171.60 million. Adjusted SG&A declined $247.08 million versus the prior year quarter to $~~132~~145.41 million, ~~reflecting~~primarily driven by the benefits of ongoing cost savings initiatives, ~~and~~partially ~~$7.3~~offset ~~million~~by ofcompensation ~~miscellaneous income primarily from an insurance recovery~~ and ~~property~~benefits ~~tax refunds~~accruals.

20Net Income, Adjusted EBITDA and Segment Adjusted EBITDA

Net income increased $98.2 million from the prior year quarter to $62.1 million.

Adjusted EBITDA declined $8.5 million versus the prior year quarter to $285.7 million. Lower Adjusted Gross Profit and Adjusted Equity Method Investment Earnings were partially offset by lower Adjusted SG&A.

North America Segment Adjusted EBITDA increased $18.6 million to $287.8 million. The increase was driven by higher volume, lower manufacturing costs per pound, and lower Adjusted SG&A, reflecting the benefit of cost savings initiatives, including operational efficiencies. These gains were partially offset by continued price and trade support for our customers.

International Segment Adjusted EBITDA declined $21.4 million to $27.2 million. The decrease was primarily attributable to higher manufacturing costs per pound, including increased fixed factory burden costs resulting from lower utilization of international production facilities and start-up expenses associated with the new production facility in Argentina. These higher manufacturing costs were partially offset by the benefit of cost savings initiatives and higher sales volume.

Interest Expense, Net

Interest expense, net increased $1.0 million, versus the prior year quarter, to $44.3 million, driven by a decline in the benefit from capitalized interest as our capacity expansion projects were all finalized prior to the second quarter of fiscal 2026. The decline in benefit from capitalized interest was partially offset by lower borrowings on our revolving credit facility.

Income Tax Expense

Income tax expense for the second quarter of fiscal 2026 and 2025 was $36.0 million and $13.4 million, respectively. The effective income tax rate (calculated as the ratio of income tax expense to pre-tax income, inclusive of equity method investment earnings) was 36.7% and (59.0)% in the second quarter of fiscal 2026 and 2025, respectively. The results in both periods reflect the impact of items outlined in the Reconciliations of Non-GAAP Financial Measures.

Table of Contents

In addition, we recorded $14.4 million of discrete tax expense in the second quarter of fiscal 2025, primarily related to the establishment of a full valuation allowance against certain international deferred tax assets. Excluding the impact of these items, the Company’s effective tax rate was 31.8% in the second quarter of fiscal 2026, versus 24.7% in the prior year quarter. Compared to the second quarter of fiscal 2025, the effective tax rate excluding the impact of these items is higher primarily due to having a larger proportion of losses in certain jurisdictions with no expected tax benefits.

Equity Method Investment Earnings

Equity method investment earnings from unconsolidated joint ventures were $3.2 million and $2.1 million for the second quarter of fiscal 2026 and 2025, respectively. Adjusted Equity Method Investment Earnings was $3.2 million and $11.1 million for the second quarter of fiscal 2026 and 2025, respectively. The decline of $7.9 million in earnings was primarily the result of lower production volume and an unfavorable mix of sales. The results for the current and prior year quarters reflect earnings associated with our 50% interest in Lamb Weston/RDO Frozen, an unconsolidated potato processing joint venture in Minnesota.

Twenty-Six Weeks Ended November 23, 2025 compared to Twenty-Six Weeks Ended November 24, 2024

Net Sales and Segment Adjusted EBITDA


	Twenty-Six Weeks Ended
(in millions, except percentages)	November 23, 2025		November 24, 2024		% Increase (Decrease)	% Increase (Decrease) at Constant Currency
Segment net sales
North America	$	2,154.0	$	2,175.8	(1)%	(1)%
International	1,123.3		1,079.2		4%	—%
	$	3,277.3	$	3,255.0	1%	(1)%

Segment Adjusted EBITDA
North America	$	547.8	$	547.2	—%
International	84.4		100.0		(16)%

Net Sales

Net sales for the first half of fiscal 2026 increased $22.3 million to $3,277.3 million compared to the prior year, including a favorable foreign currency impact of $48.0 million. Net sales at constant currency declined 1% over the first half of fiscal 2025, as a 7% increase in volume was more than offset by an 8% decline in price/mix. Volume growth was driven by customer wins, share gains, and retention, particularly in North America and Asia. Price/mix reflects continued price and trade support for our customers in the current competitive environment.

North America segment net sales for the first half of fiscal 2026, which includes all sales to customers in the U.S., Canada, and Mexico, declined $21.8 million, or 1%, to $2,154.0 million. Volume increased 7% compared to the first half of the prior year supported by recent customer contract wins, share gains and growth across channels. In response, we have restarted curtailed North American production lines. Price/mix declined 8%, driven by competitive market dynamics and an increase in price and trade to support our customers.

International segment net sales for the first half of fiscal 2026, which includes all sales to customers outside of North America, increased $44.1 million, or 4%, to $1,123.3 million year-over-year, including a favorable $47.1 million from foreign currency translation. Net sales at constant currency was flat. Volume increased 7%, driven by growth in Asia and with multinational chain customers. Price/mix at constant currency declined 7%, reflecting pricing actions in response to an increasingly competitive environment.

Gross Profit

Gross profit increased $32.9 million versus the first half of fiscal 2025 to $666.7 million. Adjusted Gross Profit declined $29.8 million versus the prior year to $666.8 million due primarily to unfavorable price/mix, increased factory burden, and costs associated with the start-up of our new production facility in Argentina. This impact was partially offset

Table of Contents

by higher volumes and benefits from cost savings initiatives. These initiatives delivered improved operational efficiencies and lower manufacturing costs per pound.

Selling, General and Administrative Expenses

SG&A declined $4.0 million versus the first half of fiscal 2025 to $324.6 million. Adjusted SG&A declined $31.8 million versus the prior year to $277.5 million, reflecting the benefits of ongoing cost savings initiatives, partially offset by compensation and benefit accruals.

Net Income, Adjusted EBITDA and Segment Adjusted EBITDA

Net income ~~declined~~increased $6335.1 million from the ~~prior~~first ~~year~~half ~~quarter~~of fiscal 2025 to $64126.34 million.

Adjusted EBITDA ~~increased~~declined $25.8 million versus the ~~prior~~first ~~year~~half ~~quarter~~of fiscal 2025 to $~~302~~285.27 million. Lower Adjusted SG&A was ~~partially~~more than offset by lower Adjusted Gross Profit and lower Adjusted Equity Method Investment Earnings ~~(Loss)~~.

North America Segment Adjusted EBITDA ~~decreased~~was ~~$18.0~~essentially ~~million~~flat toat $~~260~~547.08 million. ~~The~~in ~~decline~~the ~~primarily~~first ~~reflects~~half ~~price~~of ~~and~~fiscal ~~trade~~2026 ~~investments~~compared into ~~support~~the offirst ~~customers,~~half ~~partially~~of ~~offset~~fiscal by2025. ~~higher~~Higher sales volumes, as well as lower manufacturing costs per pound and lower Adjusted SG&A, ~~which~~both ~~included~~of ~~the~~which ~~benefit~~benefited offrom cost savings initiatives., ~~Results~~were ~~also~~offset ~~benefited~~by ~~from~~price ~~lapping~~and antrade ~~approximately~~support ~~$21~~for ~~million~~our ~~charge related to a voluntary product withdrawal in the prior year~~customers.

International Segment Adjusted EBITDA ~~increased~~declined $515.86 million to $5784.~~2 million. For the quarter ended August 24, 2025, the effects of foreign currency translation to the International Segment Adjusted EBITDA were favorable by approximately $~~4 million. The ~~increase~~decrease ~~was~~primarily ~~driven~~reflects byunfavorable ~~higher~~price/mix ~~sales volumes~~ and ~~lower~~higher manufacturing costs per pound., ~~The~~driven ~~improvement~~by ~~primarily~~lower ~~reflects~~utilization ~~lapping~~of anour ~~approximately~~international ~~$18~~production ~~million~~facilities ~~charge~~and ~~related~~start-up toexpenses ~~the~~for ~~prior~~our ~~year’s~~new ~~voluntary~~plant ~~product~~in ~~withdrawal, lower potato prices and benefits from ongoing cost savings initiatives~~Argentina. These ~~benefits~~higher manufacturing costs were partially offset by ~~$3.5~~increased ~~million~~sales involumes ~~start-up~~and ~~costs~~benefits ~~associated~~from ~~with~~cost ~~the~~savings ~~new production facility in Argentina, which is expected to support future growth~~initiatives.

Interest Expense, Net

Interest expense, net declined $10.5 million, versus the ~~prior~~first ~~year~~half ~~quarter~~of fiscal 2025, to $4388.70 million, reflecting the impact of lower total debt outstanding primarily driven by lower borrowings under our revolving credit facility, primarily offset by a decline in the benefit from capitalized interest as our capacity expansion projects were all finalized prior to the second quarter of fiscal 2026.

Income Tax Expense

Income tax expense for the first ~~quarter~~half of fiscal 2026 ~~and 2025~~ was $4783.9 million ~~and~~compared to $5064.82 million, ~~respectively~~in the prior year period. The effective income tax rate (calculated as the ratio of income tax expense to pre-tax income, inclusive of equity method investment earnings) was 4239.79% and 2841.53% infor the first ~~quarter~~half of fiscal 2026 and 2025, respectively. ~~The~~Both ~~results in both~~ periods reflect the impact of items outlined in “the Reconciliations of Non-GAAP Financial Measures~~” below~~. In the first quarter of fiscal 2026, we also recorded $10.2 million of discrete tax expense, primarily related to the establishment of a non-cash full valuation allowance against certain international deferred tax assets. Excluding the impact of these items, the Company’s effective tax rate was 30.2% in the first quarter of fiscal 2026, versus 30.8% in the prior year quarter.

OnIn ~~July~~the 4,first ~~2025,~~half ~~President~~of ~~Trump~~fiscal ~~signed~~2026 ~~into~~and ~~law~~2025, ~~the~~we ~~One~~recorded ~~Big~~$9.8 ~~Beautiful~~million ~~Bill~~and ~~Act (“OBBBA”)~~$19.2 ~~Accounting~~million ~~Standards~~of ~~Codification~~discrete ~~740~~tax expense, ~~Income Taxes~~respectively, ~~requires~~primarily related to the ~~effects~~establishment of ~~changes~~a infull ~~tax~~valuation ~~rates~~allowance ~~and~~against ~~laws~~certain tointernational bedeferred ~~recognized~~tax inassets. ~~the~~Excluding ~~period~~these initems, ~~which~~ the ~~legislation~~effective istax ~~enacted~~rate was 31.1% Wein ~~currently~~the ~~anticipate~~first ahalf ~~favorable~~of ~~cash~~fiscal ~~tax~~2026, ~~timing~~versus ~~benefit~~26.3% ofin ~~approximately~~the ~~$35~~prior ~~million~~year toperiod. ~~$45~~The ~~million~~higher inrate ~~fiscal~~compared ~~2026~~to asthe ofsecond ~~result~~half of ~~OBBBA;~~fiscal it2025 isprimarily ~~not~~reflects ~~expected~~a tolarger ~~have~~proportion aof ~~significant~~losses ~~impact~~in oncertain ~~our~~jurisdictions ~~effective~~with no expected tax ~~rate~~benefits.

~~Equity~~The ~~Method~~enactment ~~Investment~~of ~~Earnings~~the One Big Beautiful Bill Act (~~Loss~~“OBBBA”) in July 2025 introduced a wide range of tax policy changes. Key provisions include the extension of select elements of the Tax Cuts and Jobs Act, updates to the international tax framework, and the reinstatement of favorable treatment for certain business-related deductions. Accounting Standards Codification 740, Income Taxes, requires the effects of changes in tax rates and laws to be recognized in the period in which the legislation is enacted. We are actively evaluating the potential implications on our consolidated financial statements. In the first half of fiscal 2026, the impacts did not have a material effect on the tax rate. For the full year, we do anticipate a favorable cash tax timing benefit related to OBBBA.

Equity ~~method~~Method ~~investment~~Investment earnings (loss) from unconsolidated joint ventures were a loss of $0.6 million and earnings of $11.3 million for the first quarter of fiscal 2026 and 2025, respectively. The decline in earnings was primarily the result of lower net sales and an unfavorable product mix. The results for the current and prior year quarters reflect earnings associated with our 50% interest in Lamb Weston/RDO Frozen, an unconsolidated potato processing joint venture in Minnesota. Earnings

Equity method investment earnings from unconsolidated joint ventures were earnings of $2.6 million and $13.4 million for the first half of fiscal 2026 and 2025, respectively. Adjusted Equity Method Investment Earnings was $2.6 million and $22.4 million for the first half of fiscal 2026 and 2025, respectively. The decline of $19.8 million in earnings

Table of Contents

was primarily the result of lower gross profit, due primarily to sales volume and unfavorable price/mix. The results for the current and prior year reflect earnings associated with our 50% interest in Lamb Weston/RDO Frozen.

Liquidity and Capital Resources

Sources and Uses of Cash

As of ~~August~~November 2423, 2025, we had $9882.67 million of cash and cash equivalents, with $1,~~318~~350.43 million available for borrowing under our revolving credit facility. We believe we have sufficient liquidity to meet our business requirements for at least the next 12 months. Cash generated by operations, supplemented by our cash and cash equivalents and availability under our revolving credit facility, are our primary sources of liquidity for funding our business requirements. Our funding requirements include capital expenditures, working capital requirements, and shareholder returns, including cash dividends and repurchases under our share repurchase program.

Table of Contents

Cash Flows

Below is a summary table of our cash flows, followed by a discussion of the sources and uses of cash through operating, investing, and financing activities:

	Thirteen Weeks Ended
	Twenty-Six Weeks Ended
(in millions)	~~August~~November 2423,2025		~~August~~November 2524,2024
Net cash flows provided by (used for):
Operating activities	$	~~352~~530.04	$	~~330~~429.23
Investing activities	(76137.3)		(~~335~~484.69)
Financing activities	(~~248~~381.58)		5263.23
	27.2		46.8
	11.3		7.7
Effect of exchange rate changes on cash and cash equivalents	0.7		2(0.61)
Net increase in cash and cash equivalents	2712.90		497.46
Cash and cash equivalents, beginning of period	70.7		71.4
Cash and cash equivalents, end of period	$	9882.67	$	~~120~~79.80

Operating Activities

In the first ~~quarter~~half of fiscal 2026, cash provided by operating activities increased $21101.81 million to $~~352~~530.04 million. The increase largely relates to $1853.7 million of favorable changes in working capital, led by lower ~~North~~inventories ~~America~~in ~~finished~~North ~~goods inventories~~America, ~~compared~~and toa ~~the~~$47.4 ~~last~~million ~~day~~increase ofin ~~the~~net ~~first~~income, ~~quarter~~adjusted offor ~~fiscal~~non-cash ~~2025~~items.

Investing Activities

Investing activities used $76137.3 million of cash in the first ~~quarter~~half of fiscal 2026, compared with $~~335~~484.69 million in the first ~~quarter~~half of fiscal 2025. Expenditures in the first ~~quarter~~half of fiscal 2026 primarily related to our investments to expand our french fry capacity in Argentina and other production facility modernization efforts. Expenditures in the first ~~quarter~~half of fiscal 2025 primarily related to our investments to expand our french fry capacity in the Netherlands, the U.S., and Argentina. The expansion in the U.S. was completed during the fourth quarter of fiscal 2024, the expansion in the Netherlands was completed during the second quarter of fiscal 2025, and the expansion in Argentina was completed in the first quarter of fiscal 2026. In addition, we had $14.7 million of proceeds from the sale of property, plant and equipment in the first half of fiscal 2026, an increase of $13.2 million over the first half of fiscal 2025.

Financing Activities

During the first ~~quarter~~half of fiscal 2026, we made net payments of $~~161~~187.96 million under our revolving credit facilities. We used $1859.71 million of cash to repurchase ~~187~~804,~~259~~882 shares of our common stock at an average purchase price of $5562.3412 per share and towithheld ~~withhold 157~~169,~~665~~310 shares from employees to cover income and payroll taxes on ~~equity awards that~~ vested ~~during~~equity ~~the period~~awards. In addition, we paid $51103.73 million in cash dividends to common stockholders ~~during the first quarter of fiscal 2026~~ and repaid $1635.27 million of debt and financing obligations.

During the first quarter of fiscal 2025, we had net proceeds of $203.6 million under our revolving credit facility which were primarily used for general corporate purposes, including, but not limited to, funding capital expenditures and working capital requirements. We used $92.2 million of cash to repurchase 1,412,852 shares of our common stock at an average price of $58.04 per share and withheld 178,941 shares from employees to cover income and payroll taxes on equity awards that vested during the period. In addition, we paid $51.7 million in cash dividends to common stockholders and repaid $10.2 million of debt and financing obligations.24

For more information about our debt, see Note 10, Debt and Financing Obligations, of the Condensed Notes to Consolidated Financial Statements in “Part I, Item 1. Financial Statements” of this report and Note 8, Debt and Financing Obligations, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and Supplementary Data” of the Form 10-K. At August 24, 2025, we were in compliance with the financial covenant ratios and other covenants contained in our debt agreements.

Table of Contents

During the first half of fiscal 2025, we had net payments of $2.2 million under our revolving credit facility which were primarily used for general corporate purposes, including, but not limited to, funding capital expenditures and working capital requirements. We used $92.8 million of cash to repurchase 1,412,852 shares of our common stock at an average price of $58.04 per share and withheld 187,735 shares from employees to cover income and payroll taxes on vested equity awards. In addition, we paid $103.3 million in cash dividends to common stockholders and repaid $10.2 million of debt and financing obligations.

For more information about our debt, see Note 10, Debt and Financing Obligations, of the Condensed Notes to Consolidated Financial Statements in “Part I, Item 1. Financial Statements” of this report and Note 8, Debt and Financing Obligations, of the Notes to Consolidated Financial Statements in “Part II, Item 8. Financial Statements and Supplementary Data” of the Form 10-K. At November 23, 2025, we were in compliance with the financial covenant ratios and other covenants contained in our debt agreements.

Obligations and Commitments

There have been no material changes to the contractual obligations disclosed in “Management'’s Discussion and Analysis of Financial Condition and Results of Operations” in the Form 10-K.

See Note 10, Debt and Financing Obligations, of the Condensed Notes to Consolidated Financial Statements in “Part I, Item 1. Financial Statements” of this report for more information.

Non-GAAP Financial Measures

To supplement the financial information included in this report, we have presented Adjusted EBITDA, Adjusted Gross Profit, Adjusted SG&A, Adjusted Income Tax Expense, and ~~net sales, price/mix and Segment~~ Adjusted ~~EBITDA~~Equity atMethod ~~constant~~Investment ~~currency~~Earnings, each of which is considered a non-GAAP financial measure. ~~Net~~We also present net sales, and price/mix ~~and Segment Adjusted EBITDA~~ growth at constant currency, which provide information on the percentage change in net sales, and price/mix ~~and Segment Adjusted EBITDA~~ growth, respectively, as if foreign currency exchange rates had remained constant between the prior and current periods. Management uses these non-GAAP financial measures to assist in analyzing what management views as our core operating performance for purposes of business decision making. Management believes that presenting these non-GAAP financial measures provides investors with useful supplemental information because they (i) provide meaningful supplemental information regarding financial performance by excluding impacts of foreign currency exchange translation and unrealized mark-to-market derivative gains and losses and other items affecting comparability between periods, (ii) permit investors to view performance using the same tools that management uses to budget, make operating and strategic decisions, and evaluate our core operating performance across periods, and (iii) otherwise provide supplemental information that may be useful to investors in evaluating our financial ~~results~~performance. In addition, we believe that the presentation of these non-GAAP financial measures, when considered together with their most directly comparable GAAP financial measure and the reconciliations to those GAAP financial measures, provides investors with additional tools to understand the factors and trends affecting our underlying business than could be obtained absent these disclosures.

The non-GAAP financial measures presented in this report should be viewed in addition to, and not as alternatives for, financial measures prepared in accordance with GAAP that are also presented in this report. These measures are not substitutes for their comparable GAAP financial measures, such as net income, gross profit, SG&A, income tax expense, net sales, orand other measures prescribed by GAAP, and there are limitations to using non-GAAP financial measures. For example, the non-GAAP financial measures presented in this report may differ from similarly titled non-GAAP financial measures presented by other companies, and other companies may not define these non-GAAP financial measures the same way we do.

2325

Table of Contents

The following table reconciles net income to Adjusted EBITDA:

		Thirteen Weeks Ended				Twenty-Six Weeks Ended
(in millions)		~~August~~November 2423,2025		~~August~~November 2524,2024		November 23,2025		November 24,2024
Net income (a)		$	64.3	$	127.4
Net income	(a)	$	62.1	$	(36.1)	$	126.4	$	91.3
Interest expense, net		4344.73		4543.23		88.0		88.5
Income tax expense		4736.90		5013.84		83.9		64.2
Income from operations including equity method investment earnings		~~155~~142.94		~~223~~20.46		298.3		244.0
Depreciation and amortization (b)		96.3		91.4
Depreciation and amortization	(b)	99.7		92.5		195.9		183.9
Unrealized derivative gains		(4.9)		(8.9)
Unrealized derivative (gains) losses		12.1		3.0		7.2		(5.9)
Foreign currency exchange (gains) losses		(4.7)		0.6
Foreign currency exchange losses		6.8		9.6		2.1		10.2
Blue chip swap transaction gains (c)		—		(16.6)
Blue chip swap transaction gains	(c)	—		(3.3)		—		(19.9)
Stock-based compensation		109.65		912.53		20.1		21.8
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses (d)		31.9		—
Cost Savings Program, Restructuring Plan, and other expenses	(d)	14.1		159.1		46.0		159.1
Shareholder activism expense (e)		4.0		—
Shareholder activism expense	(e)	—		0.4		4.0		0.4
Pension settlement (f)		13.1		—
Pension settlement	(f)	1.1		—		14.2		—
Adjusted EBITDA		$	~~302~~285.27	$	~~299~~294.42	$	587.8	$	593.6

___________________________________________

(a)Net income during the ~~thirteen~~twenty-six weeks ended ~~August~~November 2524, 2024, reflects an approximately $39 million ($30 million after-tax, or $0.21 per share) charge related to a voluntary product withdrawal initiated in the fourth quarter of fiscal 2024. This includes an approximately $15 million charge ($11 million after-tax, or $0.08 per share) in net sales and an approximately $24 million charge ($18 million after-tax, or $0.13 per share) in cost of sales. The total charge was allocated to the reporting segments as follows: $21 million to North America and $18 million to International.

(b)Depreciation and amortization includes interest expense, income tax expense, and depreciation and amortization from equity method investments of $2.2 million and $2.10 million for the thirteen weeks ended ~~August~~November 23, 2025 and November 24, 2024, respectively, and $4.4 million and $4.1 million for the twenty-six weeks ended November 23, 2025 and ~~August~~November 2524, 2024, respectively;

(c)We entered into blue chip swap transactions to transfer U.S. dollars into Argentina primarily in connection with funding our capacity expansion in Argentina. The blue chip swap rate can diverge significantly from Argentina'’s official exchange rate.

(d)For more information about the Cost Savings Program and Restructuring Plan, see Footnote 4, Restructuring, in the Condensed Notes to Consolidated Financial Statements (unaudited), within “Part I, Item I. Financial Statements of this Form 10-Q.”

(e)Represents advisory fees related to shareholder activism matters.

(f)Pension settlement ~~charge~~charges of $131.1 million ($100.19 million after-tax, or $0.0701 per share) for the thirteen weeks ended ~~August~~November 2423, 2025, and pension settlement charges of $14.2 million ($11.0 million after-tax, or $0.08 per share) for the twenty-six weeks ended November 23, 2025. These charges were used to fully fund the Company’s defined benefit pension plan, enabling lump sum payments to participants, ~~and~~ transferring the remaining obligations and related plan assets to an insurer through a group annuity contract, and transferring remaining, unelected, assets to the Pension Benefit Guaranty Corporation.

2426

Table of Contents

The following tables reconcile gross profit to Adjusted Gross Profit, SG&A to Adjusted SG&A, ~~and~~Income ~~income~~Tax ~~tax~~Expense ~~expense~~(Benefit) to Adjusted Income Tax Expense, and Equity Method Investment Earnings to Adjusted Equity Method Investment Earnings for the thirteen weeks ended November 23, 2025 and November 24, 2024.

	For the Thirteen Weeks Ended
	August 24, 2025		August 25, 2024		August 24, 2025		August 25, 2024		August 24, 2025		August 25, 2024
	November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024
(in millions)	Gross Profit				Selling, General and Administrative				Income Tax Expense (Benefit)				Equity Method Investment Earnings
As reported	$	~~342~~324.43	$	~~356~~277.08	$	~~153~~171.60	$	~~143~~184.97	$	4736.90	$	5013.84	$	3.2	$	2.1
Unrealized derivative gains	(3.1)6		(2.9.8)		1.(8.5)		6(12.08)		(13.1)0		(20.3)8		—		—
Foreign currency exchange gains and losses	—		—		4(6.78)		(09.6)		(0.8)9		02.14		—		—
Blue chip swap transaction gains	—		—		—		163.63		—		—(0.6)		—		—
Stock-based compensation	—		—		(109.65)		(912.53)		1.6		1.59		—		—
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses	~~(0.4)~~—		—75.5		—		—		73.73		—35.5		—		9.0
Shareholder activism expense	—		—		~~(4.0)~~—		—(0.4)		~~0.9~~—		—0.1		—		—
Pension settlement	—		—		(131.1)		—		3.0.2		—		—		—
Total adjustments	(3.5)6		(265.9)7		(2125.29)		12(31.58)		119.30		(040.7)1		—		9.0
Adjusted	$	~~338~~327.9	$	~~353~~343.15	$	~~132~~145.41	$	~~156~~152.49	$	5945.20	$	5053.15	$	3.2	$	11.1

The following table reconciles net sales to net sales at constant currency for the thirteen weeks ended November 23, 2025.

The following table reconciles net sales to net sales at constant currency.


(in millions)	Net Sales		Currency		Net Sales at Constant Currency
Thirteen Weeks Ended November 23, 2025
North America	$	1,069.5	$	(1.8)	$	1,067.7
International	548.6		(22.6)		526.0
	$	1,618.1	$	(24.4)	$	1,593.7

(in millions)	Net Sales		Currency		Net Sales at Constant Currency
Thirteen Weeks Ended August 24, 2025
North America	$	1,084.6	$	0.8	$	1,085.4
International	574.7		(24.5)		550.2
	$	1,659.3	$	(23.7)	$	1,635.6

Table of Contents

The following tables reconcile gross profit to Adjusted Gross Profit, SG&A to Adjusted SG&A, Income Tax Expense (Benefit) to Adjusted Income Tax Expense and Equity Method Investment Earnings to Adjusted Equity Method Investment Earnings for the twenty-six weeks ended November 23, 2025 and November 24, 2024.


	For the Twenty-Six Weeks Ended
	November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024		November 23, 2025		November 24, 2024
(in millions)	Gross Profit				Selling, General and Administrative				Income Tax Expense (Benefit)				Equity Method Investment Earnings
As reported	$	666.7	$	633.8	$	324.6	$	328.6	$	83.9	$	64.2	$	2.6	$	13.4
Unrealized derivative gains	0.5		(12.7)		(6.7)		(6.8)		1.9		(1.6)		—		—
Foreign currency exchange losses	—		—		(2.1)		(10.2)		0.1		2.6		—		—
Blue chip swap transaction gains	—		—		—		19.9		—		(0.6)		—		—
Stock-based compensation	—		—		(20.1)		(21.8)		3.2		3.4		—		—
Items impacting comparability:
Cost Savings Program, Restructuring Plan, and other expenses	(0.4)		75.5		—		—		11.0		35.5		—		9.0
Shareholder activism expense	—		—		(4.0)		(0.4)		0.9		0.1		—		—
Pension settlement	—		—		(14.2)		—		3.2		—		—		—
Total adjustments	0.1		62.8		(47.1)		(19.3)		20.3		39.4		—		9.0
Adjusted	$	666.8	$	696.6	$	277.5	$	309.3	$	104.2	$	103.6	$	2.6	$	22.4

The following table reconciles net sales to net sales at constant currency for the twenty-six weeks ended November 23, 2025.


(in millions)	Net Sales		Currency		Net Sales at Constant Currency
Twenty-Six Weeks Ended November 23, 2025
North America	$	2,154.0	$	(0.9)	$	2,153.1
International	1,123.3		(47.1)		1,076.2
	$	3,277.3	$	(48.0)	$	3,229.3

Off-Balance Sheet Arrangements

There have been no material changes to the off-balance sheet arrangements disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Form 10-K.

Critical Accounting Policies and Estimates

A discussion of our critical accounting policies and estimates can be found in “Management'’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Form 10-K. There were no material changes to these critical accounting policies and estimates during the ~~first~~second quarter of fiscal 2026.

New and Recently Adopted Accounting Pronouncements

For a list of our new and recently adopted accounting pronouncements, see Note 1, Nature of Operations and Summary of Significant Accounting Policies, of the Condensed Notes to Consolidated Financial Statements in “Part I, Item I. Financial Statements” of this report.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As we operate globally, we are primarily exposed to currency exchange rate, commodity price and interest rate market risks. We monitor and manage these exposures as part of our overall risk management program. Our risk management program focuses on the unpredictability of financial markets and seeks to reduce the potentially adverse effects that the volatility of these markets may have on our operating results.

There have been no material changes to our market risk during the thirteen weeks ended August 24, 2025. For additional information, refer to Item 7A, Quantitative and Qualitative Disclosures about Market Risk, in the Form 10-K.28

Table of Contents

There have been no material changes to our market risk during the twenty-six weeks ended November 23, 2025. For additional information, refer to Item 7A, Quantitative and Qualitative Disclosures about Market Risk, in Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES

Inherent Limitations on Effectiveness of Controls

Because of its inherent limitations, our internal control over financial reporting may not prevent or detect misstatements. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Due to these limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks, including that controls become inadequate because of changes in conditions or that the degree of compliance with the policies and procedures may deteriorate.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of ~~August~~November 2423, 2025. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

Changes in Internal Control over Financial Reporting

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated any change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended ~~August~~November 2423, 2025, and determined that there were no changes in our internal control over financial reporting during the quarter ended ~~August~~November 2423, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

Part II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

See Note 14, Commitments, Contingencies, Guarantees and Legal Proceedings, of the Condensed Notes to Consolidated Financial Statements in “Part I, Item 1. Financial Statements” of this report for information regarding our legal proceedings.

ITEM 1A. RISK FACTORS

We are subject to various risks and uncertainties in the course of our business. The discussion of these risks and uncertainties may be found under “Part I, Item 1A. Risk Factors” in the Form 10-K. There have been no material changes to the risk factors discussed in the Form 10-K.

Table of Contents

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Total shares of Lamb Weston common stock purchased by the Company during the thirteen weeks ended ~~August~~November 2423, 2025 were as follows:

Period	Total Numberof Shares (orUnits)Purchased (a)	AveragePrice PaidPer Share(or Unit)		Total Number ofShares (or Units)Purchased as Part ofPublicly AnnouncedPlans or Programs (b)	Approximate DollarValue of MaximumNumber of Shares thatMay Yet be PurchasedUnder Plans or Programs(in millions) (b)
May 26, 2025 through June 22, 2025	405	$	55.61	—	$	358
August 25, 2025 through September 21, 2025	12,623	$	57.26	—	$	348
June 23, 2025 through July 20, 2025	45,796	$	49.83	—	358
September 22, 2025 through October 19, 2025	234,775	$	63.96	234,459	$	333
July 21, 2025 through August 24, 2025	298,723	$	54.80	187,259	348
October 20, 2025 through November 23, 2025	381,870	$	64.57	383,164	$	308
Total	~~344~~629,~~924~~268

___________________________________________

(a)Represents shares withheld from employees to cover income and payroll taxes on equity awards that vested during the period.

(b)On December 19, 2024, we announced that the Board of Directors (the “Board”) increased our total share repurchase authorization under our existing $500 million share repurchase program by $250 million to an aggregate amount of $750 million. As of ~~August~~November 2423, 2025, approximately $~~348~~308 million remained authorized and available for repurchase under the program. The program has no expiration date. Repurchases under our share repurchase program may be made at our discretion from time to time on the open market, subject to applicable laws, including pursuant to a repurchase plan administered in accordance with Rule 10b5-1 under the Exchange Act, or through privately negotiated transactions or accelerated share repurchases or other structured transactions.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Insider Trading Arrangements

Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. During the quarter ended ~~August~~November 2423, 2025, no such plans or arrangements were adopted or terminated, including by modification.

2730

Table of Contents

ITEM 6. EXHIBITS

Exhibit Number						Exhibit Description
10.1						Form of Lamb Weston Holdings, Inc. Restricted Stock Unit Agreement (FY2026 Awards)
19.1						Lamb Weston Holdings, Inc. Insider Trading Policy
10.2						Form of Lamb Weston Holdings, Inc. Performance Share Agreement (FY2026 Awards)
10.3						Form of Lamb Weston Holdings, Inc. Nonqualified Stock Option Agreement (FY2026 Awards)
31.1						Section 302 Certificate of Chief Executive Officer
31.2						Section 302 Certificate of Chief Financial Officer
32.1						Section 906 Certificate of Chief Executive Officer
32.2						Section 906 Certificate of Chief Financial Officer
101.INS						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH						XBRL Taxonomy Extension Schema Document
101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF						XBRL Taxonomy Extension Definition Linkbase Document
101.LAB						XBRL Taxonomy Extension Label Linkbase Document
101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document
104						Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)

2831

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	LAMB WESTON HOLDINGS, INC.
	By:	/s/ BERNADETTE M. MADARIETA
		BERNADETTE M. MADARIETA
		Chief Financial Officer
		(Principal Financial Officer)
Dated this 30th day of September, 2025
Dated this 19th day of December, 2025

2932

Filing Compare · Lamb Weston Holdings, Inc.